Education
Professional Experience
Hospital Appointments
Licensure and Certification
Professional Organizations
Committees
Honors and Awards
Grant Support
Bibliography
Articles
Book Chapters
Books
Abstracts
Presentations
1968, B.S. - Honors in Biology
Quincy College
1972, M.D.
St. Louis University School of Medicine
1972-1980
Post Graduate Education
University of Minnesota, Department of Surgery
Intern, 1972-1973
Resident, 1973-1978
Chief Resident, 1978-1979
Fellow (Transplantation), 1980
2006-Present, Executive Medical Director Transplant Services
University of Minnesota Medical Center, Fairview
1995-Present, Professor of Surgery
University of Minnesota, Department of Surgery
7/1/89-12/31/94, Associate Professor
University of Minnesota, Department of Surgery
1986-6/30/89, Assistant Professor
University of Minnesota, Department of Surgery
1988-Present, Surgical Director, Liver Transplant Program
University of Minnesota, Department of Surgery
1986-Present, Director, Vascular Surgical Services
University of Minnesota, Department of Surgery
1986-1988, Chief, Vascular Section, Surgery Service
Veterans Affairs Medical Center, Minneapolis, Minnesota
1985-1988, Director, Vascular Diagnostic Laboratory
Special Team for Amputation, Mobility, and Prosthetics/Orthotics (STAMP)
Veterans Affairs Medical Center, Minneapolis, Minnesota
1983-1992, Chief, Transplant Section, Surgery Service
Veterans Affairs Medical Center, Minneapolis, Minnesota
1983-1986, Instructor
University of Minnesota, Department of Surgery
1981-1982, Assistant Professor
University of Texas Medical School at Houston
Department of Surgery, Division of Immunology and Organ Transplantation
1979-1980, Instructor
University of Minnesota, Department of Surgery
Chief, Transplant Section
Veterans Affairs Medical Center, Minneapolis, Minnesota
Active Staff
Minneapolis Veterans Affairs Medical Center
Minneapolis, Minnesota
Attending Staff
University of Minnesota Medical Center, Fairview
Minneapolis, Minnesota
Minnesota State Board of Medical Examiners
American Board of Surgery – April 15, 1980
Recertification – October 13, 1989
Special Qualifications in General Vascular Surgery 9#653) – June 11, 1987
Recertification – October 18, 1996
Recertification – October 6, 2006
American College of Surgeons
American Medical Association
American Society of Transplant Surgeons
Association or Academic Surgery
Midwestern Vascular Surgery Society
Minneapolis Surgical Society
Minnesota Chapter of the American College of Surgeons
Minnesota Vascular Society
Transplantation Society
Twin City Thoracic and Cardiovascular Society
American Surgical Association, Fellow (06/07)
1985 – 1988, Advisory Board, Transplant Donor Services, American Red Cross, St. Paul Chapter
1985 – 1993, Organ Procurement and Distribution Committee, United Network for Organ Sharing (UNOS) (Chairman, 1990-1991)
1986 – 1988, Health Care Monitoring Board, Minneapolis VA Medical Center
1987 – Present, Board of Directors, LifeSource/Upper Midwest Organ Procurement Organization, Inc. (President, 1987-1990)
1987 – 1989, Biomedical Ethics Committee, University of Minnesota Hospitals
1987 – Present, Board of Directors, Institute for Basic and Applied Research in Surgery (IBARS), Treasurer (2007-present)
1988 – Search Committee for Head of the Division of Cardiovascular and Thoracic Surgery
1988 – 2000, Minnesota Vascular Society, President
1988 – 2004, Minnesota Vascular Society, Treasurer
1988 – Present, Minnesota Vascular Society, Board of Directors
1988 – 1990, Histocompatibility Committee, UNOS
1988 – 1990, Executive Committee, The Research Core Center for the Study of Advanced Liver Diseases
1989 – Biomedical Ethics Committee, Anencephalic Infant Policy Task Force, University of Minnesota Hospitals
1990 – 1992, Member, Membership and Professional Standards Committee, UNOS
1990 – 1992, Member, Scientific Advisory Committee, UNOS
1990 – exp., Advisory Committee Member, MN Assoc of Public Teaching Hospitals (MAPTH RAP)
1991 – 1992, Member, Bylaws Committee, American Society for Transplant Surgeons
1991 – 1996, Representative of Unit II, Medical Staff – Hospital Council
1992 – 1993, Member, Local Committee, First International Congress on Pediatric Transplantation
1992 – 1996, Chairman, Search Committee, Vascular Surgeon
1993 – 1994, Member, Search Committee, Head, Department of Surgery
1993 – 1994, Search Committee, Chief Financial Officer
1993 – Present, Member, Departmental Advisory Council
1993 – Present, UMCA Program Development Committee
1993 – 1997, UMCA Transplant Work Group
1993 – Present, Physician Ethics Liaison Team
1993 – 1995, Transplant Clinical Pathways
1993 – Liver Transplant Resource Utilization Committee
1994 – Present, Vascular Program Committee
1994 – Present, Children’s Program Medical Staff Group
1995 – 1996, Region 7 Associate Councillor to UNOS
1995 – 1996, Regional Representative, Membership and Professional Standards Committee, UNOS
1995 – 1996, Tissue and Procedure Review Committee
1995 – 1996, Transfusion Therapeutics Committee
1995 – 1996, Departmental Programmatic Requests Committee
1995 – Search Committee, Pediatric Cardiovascular Surgeon
1995 – 1996, Search Committee, Department of Surgery, Development Officer
1995 – Present, Hennepin Medical Society, Board of Directors
1995 – 1996, Search Committee, Director of Gastroenterology
1996 – 1997, Region 7 Councillor to UNOS
1995 – Fairview-University Medical Center, Discharge Process Task Force
1995 – UMHC Ethical Program Practices and Task Force
1995 – Search Committee, Vascular Surgeon, VA Medical Center
1995 – exp., Steering Committee, Digestive Disease Center
1995 – UMHC Patient Satisfaction Steering Committee
1995 – Present, Department of Surgery, Faculty Promotion and Tenure Committee
1997 – Fairview-University Medical Center Patient Care Committee of the Board
1997 – Fairview-University Medical Center Executive Committee
1997 – Fairview-University Medical Center Care Delivery Steering Committee
1997 – Fairview-University Medical Center Ethics Committee
1997 – Present, Department of Surgery, Solid Organ Transplant Strategy Group
1997 – Department of Surgery, Research and Grants Management Committee
1997 – 2002, Treasurer, Minnesota Vascular Society
1998 – 1999, Vice President/President-Elect, UNOS
1999 – 2000, Chief of Staff, Fairview-University Medical Center
1999 – 2000, President, UNOS
1999 – exp., President, Minnesota Vascular Society
2000 – Present, Department of Surgery, CSU Management Committee
2000 – 2001, Past-President, UNOS
2000 – 2003, Board of Directors, University of Minnesota Physicians (UMP)
2001 – 2002, Past Chief of Staff, Fairview-University Medical Center
2002 – Present, University of Minnesota Physicians, Budget and Finance Committee (Chair: June 8, 2005-Present)
2002 – Present, University of Minnesota, Medical School, Admissions Committee
2004 – 2006, UMP, Credentials Committee
2005 – 2006, Search Committee, Department of Surgery Chair, UMMC
2004 – 2006, UMMC Fairview, Medical Staff, Credentials Committee
2004 – 2006, UMP, Committee on Committees
2005 – 2006, UMP, Executive Compensation Committee
2005 – 2006, UMP, Nominations Committee
2006 – Present, UMP Interdisciplinary Program Development Committee
2007 – Present, The Institute for Basic and Applied Research in Surgery (IBARS), Treasurer
2006 – Present, Owen Wangesteen Surgical Society, Board of Governors
National Research Service Award, NIH, 1975 - 1977
Schering Scholarship, American College of Surgeons, 1978
National Research Service Award, NIH, 1978, declined
Visiting Professor, University of Puerto Rico, March 10-12, 1985
Visiting Professor, Colombian College of Surgeons, April 30-May 3, 1985
2005 – Present
Co-Sub-Investigator (with John Lake); Principal Investigator: Abhinav Humar
“A prospective, open-label, multi-enter, randomized trial of the efficacy and safety of a long-term calcineurin inhibitor-free maintenance regimen with mycophenolate mofetil and sirolimus in recipients of an orthotopic liver transplant, Roche Laboratories, Inc.
2005 – Present
NIH NHLBI National Heart Lung, 01/01/05-12/31/08.
Co-Investigator (with Steven Santilli)
“Artery Wall”
2006 – Present
NIH 04/01/06-3/31/11
Co-Investigator (with Steven Santilli)
“Stent Induced Artery Wall Hypoxia and Intimal Hyperplasia”
2005 – (Submitted)
Secondary Mentor (with Alan Hirsch), University of Minnesota Vascular Medicine Clinical Research Fellowship: Research Career Development Programs in Vascular Medicine. RFA Number: FRA-HL-05-002
1988 – 1993
Advisor, "Research Training for Surgical Scientist"
(PI: John S. Najarian), NIH DK07566
1987 – 1992
Principal Investigator, "In-vitro Preparation of Hepatocytes for
Transplantation," Experimental Project Ia in Program Project Grant, "Organ Transplantation in Animals and Man" (JS Najarian, Program Investigator), NIADDKD 5 P01 13083
1987 – 1992
Principal Investigator, "The Comparative Use of OKT3 Mab versus MALG to Reverse Rejection of Human Liver Allografts: A Prospective Randomized Study," Clinical Project Ib in Program Project Grant, "Organ Transplantation in Animals and Man" (JS Najarian, Program Investigator), NIADDKD 5 P01 13083
1987 – 1992
Co-Principal Investigator, "Immunogenicity of Pancreatic Islets,"
Experimental IB Project Grant, "Organ Transplantation in Animals and Man" (JS Najarian, Program Investigator), NIADDKD 5 P01 13083
1989 – 1991
Co-Principal Investigator, "A Hepatodialysis Bioreactor as Mechanical Support of Liver Failure," National Science Foundation, NSF/BCS-8915307
1988 – 1989
Co-Investigator, "Immunosuppressive Factor(s) in Hepatocyte Cytosol," Feasibility Project in "The Research Core Center For the Study of Advanced Liver Diseases," NIH DK34931
1988 – 1989
Co-Investigator, "Effect of Anti-Class I MAB on Hepatocyte Transplantation," Feasibility Project in "The Research Core Center for the Study of Advanced Liver Diseases," NIH DK34931
1986 – 1989
Principal Investigator, "Liver Transplant Database," (Subcontract #7441-1), University of Pittsburgh, NIDDK
1982 – 1989
Advisor, "Immunology and Its Relation to Surgery," (PI: John S. Najarian), NIH CA09024
1987 – 1988
Principal Investigator, "Environmental Regulation of Cell Activity in Wound Healing," Veterans Administration Merit Review Program
1986 – 1987
Principal Investigator, "Reversibility of Liver Disease Associated with Long-Term TPN and Short Bowel Syndrome Using Small Bowel Transplantation," Minnesota Medical Foundation Research Grant
1981 – 1982
Principal Investigator, "Altering the Immunogenicity of Pancreatic
Islet Allografts," Biomedical Research Support Grant, University of Texas Health Sciences Center, Houston
1977 – 1979
Co-Investigator, "Allogenic Transplantation of Pancreatic Islets,"
American Diabetes Association of Minnesota
1977
Principal Investigator, "DL-Ethionine Treatment of Donors Prior to Transplantation of Dispersed Pancreatic Tissue in Large Animal Model of Diabetes - The Pancreatectomized Dog," American Diabetes Association of Minnesota
Top of page
BIBLIOGRAPHY
1. Simmons RL, Payne WD, Sutherland DER, Howard RJ, Goetz FC, Barbosa J,
Kjellstrand CM, and Najarian JS: Special problems in diabetic renal transplantation. Urol
Clin North Am 3: 3: 691-699, 1976.
* 2. Matas AJ, Payne WD, Simmons RL, Buselmeier TJ, and Kjellstrand CM: Acute renal
failure following blunt civilian trauma. Ann Surg 185: 3: 301-306, 1977.
* 3. Matas AJ, Sutherland DER, Payne WD, Kretschmer GJ, Steffes MW, and Najarian JS:
Islet transplantation: The critical period of donor ischemia in neonatal rats.
Transplantation 23: 3: 295-298, 1977.
* 4. Payne WD, Michels S, Toledo-Pereyra LH, Simmons RL, and Najarian JS: Effects of
pulsatile perfusion on the immunogenicity of renal allografts. J Surg Res 22: 4: 380-384,
1977.
5. Payne WD, Matas AJ, Simmons RL, and Najarian JS: Perfusion nephropathy. N Engl J
Med 296: (March 3): 514, 1977.
6. Payne WD and Simmons RL: Immunological studies in organ preservation. Transplant
Proc 9: 3: 1629-1634, 1977.
7. Matas AJ, Sutherland DER, Payne WD, Grotting J, Steffes MW, Kretschmer GJ, and
Najarian JS: Successful transplantation of neonatal rat islet tissue preserved for up to 63
hours. Trans Am Soc Artif Int Organs 23: 347-350, 1977.
8. Payne WD, Sutherland DER, Matas AJ, and Najarian JS: Amelioration of diabetes in
rats by transplantation of islet tissue from single donor to multiple recipients. Surg
Forum 28: 301-304, 1977.
9. Payne WD and Simmons RL: Renal transplantation in patients with urologic
abnormalities. Transplantation and Clinical Immunology, Vol. IX. (Proc. 9th
International Course, Lyon, France, June 6-8, 1977). Excerpta Medica, Amsterdam
Oxford, 1978, p. 133-139.
* 10. Matas AJ, Payne WD, Grotting JC, Sutherland DER, Steffes MW, Hertel BF, and
Najarian JS: Portal vs. systemic transplantation of dispersed neonatal pancreases.
Transplantation 24: 5: 333-337, 1977.
* 11. Matas AJ, Sutherland DER, Payne WD, Eckhardt J, and Najarian JS: A mouse model of
islet transplantation using neonatal donors. Transplantation 24: 5: 389-393, 1977.
* 12. Numata M, Sutherland DER, Payne WD, Najarian JS, and Simmons, RL: Failure of
Concanvalin A perfusion to prolong kidney allograft survival in rats.
Transplantation 25: 6: 339-340, 1978.
* 13. Vialettes B, Sutherland DEW, Payne WD, Matas AJ, and Najarian JS: Synergistic effect of donor specific soluble membrane antigen injection and antilymphocyte serum administration on the survival of islet allografts in rats. Transplantation 25: 6:
336-338, 1978.
* 14. Kretschmer GJ, Sutherland DER, Matas AJ, Payne WD, and Najarian JS: Autotransplantation of pancreatic fragments to the portal vein and spleen of totally pancreatectomized dogs: A comparative evaluation. Ann Surg 187: 1: 79-86, 1978.
* 15. Matas AJ, Payne WD, Sutherland DER, and Najarian JS: On the interpretation of islet allograft and xenograft results. Transplantation 25: 5: 281-283, 1978.
* 16. Grotting JC, Rosai J, Matas AJ, Frenzel EM, Payne WD, Sutherland DER, and Najarian JD: The fate of intraportally transplanted islets in diabetic rats: A morphologic and immunohistochemical study. Am J Pathol 92: 3: 653-670, 1978.
17. Vialettes B, Matas AJ, Sutherland DER, Payne WD, and Najarian JS: Effect of islet transplantation on plasma lipid levels in diabetic rats. Surg Forum 29: 345-347, 1978.
18. Payne WD, Sutherland DER, Matas AJ, and Najarian JS: Cryopreservation of neonatal rat islet tissue. Surg Forum 29: 347-349, 1978.
* 19. Hau T, Payne WD, and Simmons RL: Pathogenesis of intraperitoneal adhesions: Peritoneal fibrinolytic activity during experimental peritonitis. Surg Gynecol Obstet 148: (March): 415-418, 1979.
* 20. Payne WD, Sutherland DER, Matas AJ, Gorecki P, and Najarian JS: DL-ethionine treatment of adult pancreatic donors: Amelioration of diabetes in multiple recipients with tissue from a single donor. Ann Surg 189: 2: 248-256, 1979.
21. Sutherland DER, Lum CT, Payne WD, and Najarian JS: Effect of pretreatment with donor blood on renal allograft survival in dogs stratified by DLA match and MLC reactivity. Transplant Proc 11: 1: 160-166, 1979.
* 22. Vialettes B, Sutherland DER, Matas AJ, Payne WD, and Najarian JS: Amelioration of streptozotocin-induced diabetes in rats: Effect of islet isografts on plasma lipids and other metabolic abnormalities. Metabolism 28: 5: 489-494, 1979.
23. Sutherland DER, Frenzel E, Payne WD, Matas AJ, and Najarian JS: Transplantation of adult islet tissue in rats: Spleen vs. portal vein site. Surg Forum 30: 305-307, 1979.
* 24. Lum CT, Sutherland DER, Payne WD, Gorecki P, Matas AJ, and Najarian JS: Prolongation of mouse and rat pancreatic islet cell allografts by adenosine deaminase inhibitors and adenine arabinoside. J Surg Res 28: 1: 44-48, 1980.
25. Sutherland DER, Goetz FC, Rynasiewicz JJ, Kawahara K, Matas AJ, Payne WD, Baumgartner D, and Najarian JS: Pancreas and islet transplantation for clinical and experimental diabetes. In Bibergeil H, Zuhlke H, Poser U (eds): Proc of X Karlsburg Symposium: Early Diabetes-Pathogenesis, Diagnosis, Prevention. Cent. Diabetes Gerhardt Katsch, Karlsburg, pp. 225-278, 1980.
* 26. Matas AJ, Sutherland DER, Payne WD, Van Hook EJ, Simmons RL, and Najarian JS: Retrieval of kidneys for transplantation from cadaver donors in Minnesota: One center's experience. Minn Med 65: 163-166, 1982.
* 27. Kahan BD, Van Buren CT, Lin SN, Ono Y, Agostino G, LeGrue SJ, Boileau M, Payne WD, and Kerman RH: Immunopharmacological monitoring of Cyclosporin A-treated recipients of cadaveric kidney allografts. Transplantation 34: 1: 36-45, 1982.
* 28. Flechner SM, Rauschkolb EN, Cohen G, Sandler CM, Ben-Menachem Y, Van Buren CT, Payne WD, and Kahan BD: Use of digital subtraction angiography for the evaluation of living related renal transplant donors. Transplantation 33: 6: 645-647, 1982.
29. Kerman R, Van Buren CT, Payne W, Flechner S, Agostino G, Conley S, Brewer E, and Kahan BD: Influence of blood transfusions on immune responsiveness. Transplant Proc 14: 2: 335-337, 1982.
* 30. Van Buren CT, Kerman R, Agostino G, Payne W, Flechner S, and Kahan BD: The cellular target of Cyclosporin A action in man. Surgery 92: 2: 167-174, 1982.
* 31. Kahan BD, Van Buren CT, Boileau M, Payne WD, Flechner S, and Newburger J: Cyclosporin A tissue levels in cadaveric renal allograft recipient. Transplantation 35: 1: 96-99, 1983.
32. Flechner SM, Kerman RH, Van Buren C, Payne WD, and Kahan BD: The use of cyclosporine and prednisone for high MLC haploidentical living related renal transplants. Transplant Proc 15: 1: 442-445, 1983.
33. Kerman R, Van Buren C, Payne WD, Flechner S, and Kahan BD: Monitoring of T cell subsets and immune events in renal allograft recipients. Transplant Proc 15: 1: 1170-1172, 1983.
34. Kerman RH, Agostino G, Van Buren CT, Payne W, Flechner S, Conley S, Brewer E, and Kahan BD: Effect of blood transfusions on graft survival and immune responsiveness. Transplant Proc 15: 1: 1022-1025, 1983.
35. Van Buren CT, Kerman RH, Agostino G, Flechner SM, Payne WD, and Kahan BD: Effect of cyclosporine on immunoregulatory cells of renal allograft recipients. Transplant Proc 15: 1: 527-530, 1983.
* 36. Payne WD, Sutherland DER, Matas AJ, and Najarian JS: Successful long-term cryopreservation of neonatal rat islet tissue. Cryobiology 20: 226-230, 1983.
* 37. Kerman RH, Van Buren CT, Payne W, Flechner S, Agostino G, Conley S, Brewer E, and Kahan BD: The influence of pretransplant blood transfusions from random donors on immune parameters affecting cadaveric allograft survival. Transplantation 36: 1: 50-54, 1983.
* 38. Flechner SM, Payne WD, Van Buren C, Kerman R, and Kahan BD: The effect of cyclosporine on early graft function in human renal transplantation. Transplantation 36: 3: 268-272, 1983.
* 39. Flechner SM, Sandler CM, Childs T, Ben-Menachem Y, Van Buren C, Payne W, and Kahan BD: Screening for transplant renal artery stenosis in hypertensive recipients using digital subtraction angiography. J Urol 130: 440-444,1983.
40. Kerman RH, Payne W, Van Buren CT, Flechner S, and Kahan BD: Detection of host presensitization to donor alloantigens utilizing a comprehensive immune crossmatch. Transplant Proc 15: 3: 1815-1816, 1983.
41. Kerman RH, Flechner S, Van Buren CT, Payne W, and Kahan JBD: Cyclosporin improves allograft survival in immunologically high-risk renal allograft recipients. Transplant Proc 15: 3: 1909-1911, 1983.
42. Kerman RH, Van Buren CT, Flechner S, Payne W, and Kahan BD: Immune monitoring of renal allograft recipient treated with cyclosporine or azathioprine using donor and nonspecific assays and monoclonal T cell reagents. Transplant Proc 15: 3: 1971-1973, 1983.
43. Kerman RH, Flechner SM, Van Buren CT, Payne W, and Kahan BD: Immunologic monitoring of renal allograft recipients treated with cyclosporine. Transplant Proc 15: 4: Suppl 1: 2302-2305, 1983.
44. Kahan BD, Van Buren CT, Flechner SM, Payne WD, Boileau M, and Kerman RH: Cyclosporine immunosuppression mitigates immunologic risk factors in renal allotransplantation. Transplant Proc 15: 4: Suppl 1: 2469-2478, 1983.
45. Aeder MI, Payne WD, Jeng LB, Sutherland DER, and Najarian JS: Use of enteral cyclosporine for small intestinal allotransplantation in dogs. Surg Forum 35: 387-390, 1984.
46. Najarian JS, Weiland D, Chavers B, Simmons RL, Payne WD, Ascher NL, and Sutherland DER: Studies on living related kidney donors at a single institution. Proc Eur Dialysis Transplant Assoc-Eur Renal Assoc Vol. 21, 1984.
* 47. Dunn DH, Rodriquez E, Vennes J, Payne W: Intrahepatic biliary stricture in association with choledochal cyst. Minn Med 67: 367-369, 1984.
48. Sutherland DER, Payne WD, Fryd DS, Strand MH, Ascher NL, Simmons RL, and Najarian JS: Comparison of cyclosporine and azathioprine for immunosuppression in diabetic and nondiabetic renal allograft recipients. Transplant Proc 17: 1: 1204-1211, 1985.
49. Canafax DM, Martel EJ, Ascher NL, Payne WD, Sutherland DER, Simmons RL, and Najarian JS: Two methods of managing cyclosporine nephrotoxicity: Conversion to azathioprine, prednisone, or cyclosporine, azathioprine and prednisone. Transplant Proc 17: 1: 1176-1177, 1985.
* 50. Najarian JS, Fryd DS, Strand M, Canafax DM, Ascher NL, Payne WD, Simmons RL, and Sutherland DER: A single institution, randomized, prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients. Ann Surg 201: 2: 142-157, 1985.
* 51. Sutherland DER, Fryd DS, Strand MH, Canafax DM, Ascher NL, Payne WD, Simmons RL, and Najarian JS: Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients. Am J Kidney Dis 5: 6: 318-327, 1985.
52. Simmons RL, Canafax DM, Strand M, Ascher NL, Payne WD, Sutherland DER, and Najarian JS: Management and prevention of cyclosporine nephrotoxicity after renal transplantation: Use of low doses of cyclosporine, azathioprine, and prednisone. Transplant Proc 17: 4: Suppl 1: 266-275, 1985.
* 53. Sutherland DER, Fryd DS, Payne WD, Ascher N, Simmons RL, and Najarian JS: Renal transplantation in diabetics at the University of Minnesota. Diab Nephrop 4: 3: 123-126, 1985.
54. Sibley RK and Payne W: Morphologic findings in the renal allograft biopsy. Semin Nephrol 5: 4: 294-306, 1985.
55. Payne WD, Simons RL, Canafax DM, Strand M, Ascher NL, Sutherland DER, and Najarian JS: Newer clinical protocols of immunosuppression. Transplant Proc 17: Suppl 2: 44-48, 1985.
* 56. Canafax DM, Torres A, Fryd DS, Heil JE, Strand MH, Ascher NL, Payne WD, Sutherland DER, Simmons RL, and Najarian JS: The effects of delayed function on recipients of cadaver renal allografts: A study of 158 patients randomized to cyclosporine or ALG-Azathioprine. Transplantation 41: 2: 177-181.
* 57. Regotti P, Van Buren CT, Payne WD, Peters C, and Kahan BD: Gastrointestinal perforations in renal transplant recipients immunosuppressed with cyclosporin. World J Surg 10: 1: 137-141, 1986.
58. Payne WD: Introduction to renal transplantation. Semin Interven Radiol 3: 2: 83-88, 1986.
59. Canafax DM, Sutherland DER, Simmons RL, Fryd DS, Ascher NL, Payne WD, and Najarian JS: Combination immunosuppression: Three drugs (azathioprine, cyclosporine, prednisone) for mismatched related and four drugs (antilymphocyte globulin, azathioprine, cyclosporine, prednisone) for cadaver renal allograft recipients. Transplant Proc 17: 6: 2671-2672, 1985.
60. Canafax DM, Martel EJ, Sutherland DER, Fryd DS, Ascher NL, Payne WD, Simmons RL, and Najarian JS: Management of cyclosporine nephrotoxicity by conversion to azathioprine or by reduction of cyclosporine dose and addition of azathioprine. Transplant Proc 17: 6: 2677-2678, 1985.
61. Simmons RL, Canafax DM, Fryd DS, Ascher NL, Payne WD, Sutherland DER, and Najarian JS: New immunosuppressive drug combinations for mismatched related and cadaveric renal transplantation. Transplant Proc 18: 2: Suppl 1: 76-81, 1986.
62. Canafax DM, Simmons RL, Sutherland DER, Fryd DS, Strand MH, Ascher NL, Payne WD, and Najarian JS: Early and late effects of two immunosuppressive drug protocols on recipients of renal allograft: Results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine. Transplant Proc 18: 2: Suppl 1: 192-196, 1986.
63. Canafax DM, Sutherland DER, Fryd DS, Ascher NL, Payne WD, Simmons RL, and Najarian JS: The benefits of immunosuppressive drug combinations for diabetic recipients of cadaver and HLA mismatched related renal allografts. Transplant Proc 18: 6: 1728-1729, 1986.
* 64. Najarian JS, So SKS, Simmons RL, Fryd DS, Nevins TE, Ascher NL, Sutherland DER, Payne WD, Chavers BM, and Mauer SM: The outcome of 304 primary renal transplants in children (1968-1985). Ann Surg 204: 3: 246-258, 1986.
* 65. Migliori RJ, Simmons RL, Payne WD, Asher NL, Sutherland DER, Najarian JS, and Fryd D: Renal transplantation done safely without prior chronic dialysis therapy. Transplantation 43: 1: 51-55, 1987.
66. Migliori RJ, Simmons RL, Fryd D, Noreen H, Ascher NL, Sutherland DER, Payne W, and Najarian JS: HLA-DR tissue typing may be ignored for first but not subsequent cadaver renal transplants. Transplant Proc 19: 1: 689-690, 1987.
67. Stock P, Sutherland DER, Fryd DS, Ascher NL, Payne WD, Simmons RL, and Najarian JS: Detrimental effect of ABO mismatching in renal transplantation. Transplant Proc 19: 1: 711-712, 1987.
68. Pescovitz MD, Gruber SA, Ascher NL, Kruse LVG, Najarian JS, Payne WD, Simmons RL, Sutherland DER, and Fryd DS: Frequency of diabetes-related complications in renal allograft recipients prospectively randomized to cyclosporine or azathioprine. Transplant Proc 19: 1: 1537-1538, 1987.
69. Fryd D, Migliori RJ, Ascher NL, Payne W, Sutherland DER, Simmons RL, and Najarian JS: Can renal transplantation be done safely without prior dialysis therapy? Transplant Proc 19: 1: 1557-1558, 1987.
70. Boudreaux JP, McHugh L, Canafax DM, Ascher N, Sutherland DER, Payne W, Simmons RL, Najarian JS, and Fryd DS: Cyclosporine;, combination immunosuppression, and posttransplant diabetes mellitus. Transplant Proc 19: 1: 1811-1813, 1987.
* 71. Boudreaux JP, McHugh L, Canafax DM, Ascher NL, Sutherland DER, Payne W, Simmons RL, Najarian JS, and Fryd DS: The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation 44: 3: 376-381, 1987.
72. Gruber SA, Pescovitz M, Simmons RL, Najarian JS, Ascher NL, Payne WD, Sutherland DER, Elick B, and Fryd DS: Thromboembolic complications after renal transplantation: Results form the randomized trial of cyclosporine vs. azathioprine-antilymphocyte globulin. Transplant Proc 19: 1: 1815-1816, 1987.
73. Canafax DM, Savik SK, Draxler CA, Le CT, Ascher NL, Payne WD, Sutherland DER, Migliori RJ, Simmons RL, Najarian JS, and Fryd DS: Cox regression analysis of outcome risk factors in 519 renal allograft recipients. Transplant Proc 19: 1: 1947-1948, 1987.
74. Najarian JS, So SKS, Simmons RL, Mauer SM, Nevins TE, Sutherland DER, Ascher NL, Chavers BM, Payne WD, and Fryd DS: First kidney transplants in children 5 years of age or younger. Transplant Proc 19: 1: 2111-2112, 1987l.
75. Stock P, Estrin JA, Fryd DS, Payne WD, Belani KG, Elick BA, Najarian JS, and Ascher NL: Prognostic perioperative factors predicting the outcome of liver transplantation. Transplant Proc 19: 1: 2427-2428, 1987.
76. Stock PG, Sutherland DER, Fryd DS, Ascher NL, Payne W, Simmons RL, Najarian JS: ABO compatible mismatching decreases 5-year actuarial graft survival after renal transplantation. Transplant Proc 19: 6: 4522-4524, 1987.
77. St. Cyr JA, Elick B, Freese D, harp H, Payne W. Bloomer J, Stock P, Snover D, Najarian JS, and Ascher L: Use of triple therapy and percutaneous needle biopsy to minimize graft failure following liver transplant. Transplant Proc 19: 1: 2451-2453, 1987.
* 78. Stock PG, Snover D, Payne W, Dunn DL, Simmons RL, Najarian JS, and Ascher NL: Biopsy-guided immunosuppressive therapy in the treatment of liver transplant rejection: An individualized approach. Clin Transplantation 1: 4: 179-186, 1987.
79. Sutherland DER, Fryd DS, Payne WD, Ascher NL, Simmons RL, and Najarian JS: Kidney transplantation in diabetic patients. Transplant Proc 19: 2: Suppl 2: 90-94, 1987.
* 80. Gruber SA, Pescovitz MD, Simmons RL, Najarian JS, Ascher NL, Payne W, Sutherland DER, and Fryd DS: Thromboembolic complications in renal allograft recipients: A report from the prospective randomized study of cyclosporine versus azathioprine-antilymphocyte globulin. Transplantation 44: 6: 775-778, 1987.
* 81. Chan GLC, Canafax DM, Ascher NL, Dunn DL, Payne WD, Fryd DS, Noreen H, Sutherland DER, Simmons RL, and Najarian JS: HLA-identical sibling renal transplants: No rejections with a cyclosporine-azathioprine-prednisone protocol. Clin Transplantation 2: 9-14, 1988.
* 82. Johnson CP, Simmons RL, Sutherland DER, Canafax DM, Ascher NL, Payne WD, Elick B, Najarian JS, and Fryd DS: A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 ½ - 6 years. Transplantation 45: 2: 380-385, 1988.
83. Roberts JP, Fryd DS, Ascher NL, Migliori R, Payne WD, Dunn DL, Sutherland DER, Simmons RL, and Najarian JS: Living related kidneys continue to provide superior results over cadaveric kidneys in the cyclosporine era. Transplant Proc 20: 1: Suppl 1: 26-27, 1988.
* 84. Gruber SA, Simmons RL, Najarian JS, Vercellotti G, Ascher NL, Dunn DL, Payne WD, Sutherland DJJER, and Fryd DS: Posttransplant erythrocytosis and the risk of thromboembolic complications: Correlation from a prospective randomized study of cyclosporine versus azathioprine-antilymphocyte globulin. Clin Transplantation 2: 2: 60-66, 1988.
85. Hughes CE, Serstock D, Wilson BD, and Payne W: Infection with trichosporon pullulans. Ann Intern Med 108: 5: 772-773, 1988.
* 86. Gruber SA, Fryd DS, Chavers B, Canafax DM, Payne WD, Simmons RL, and Najarian JS: Editorial comments: The thrombogenicity of cyclosporine. Clin Transplantation 2: 3: 99-101, 1988.
87. Gruber SA, Simmons RL, Najarian JS, Vercellotti G, Ascher NL, Dunn DL, Payne WD, Sutherland DER, and Fryd DS: Erythrocytosis and thromboembolic complications after renal transplantation: Results from a randomized trial of cyclosporine versus azathioprine-antilymphocyte globulin. Transplant Proc 20: 3: Suppl 3: 948-950, 1988.
88. Bumgardner GL, Stock PG, Payne WD, Najarian JS, and Ascher NL: Comparative results of hepatic transplantation in pediatric and adult recipients. Der Chirug 59: 526-535, 1988. (Translated into German).
89. Najarian JS, Migliori RJ, Simmons R, Ascher NL, Payne WD, Dunn D, Sutherland DER, and Fryd DS: Effects of HLA matching in cadaver renal transplants. Transplant Proc 20: 3: Suppl 3: 249-256, 1988.
* 90. Ascher NL, Stock PG, Bumgardner GL, Payne WD, and Najarian JS: Infection and rejection of primary hepatic transplant in 93 consecutive patients treated with triple immunosuppressive therapy. Surg Gynecol Obstet 167: (December): 474-484, 1988.
91. Canafax DM, Sutherland DER, Matas AJ, Payne WD, Dunn DL, and Najarian JS: Cyclosporine and immunosuppressive regimens in renal transplantation (Letter to the Editor). N Engl J Med 319: 19: 1287-1288, 1988.
* 92. Bumgardner GL, Mauer SM, Payne W, Dunn DL, Sutherland DER, Fryd DS, Mauer SM, Ascher NL, Simmons RL, and Najarian JS: Single center 1-15 year results of renal transplantation in patients with systemic lupus erythematosus. Transplantation 46: 5: 703-709, 1988.
* 93. Coleman CC, Posalaky IP, Robinson JD, Payne WD, Vlodaver ZA, Amplatz K: Atheroablation with the Kensey catheter: A pathologic study. Radiology 170: 2: 391-394, 1989.
* 94. Letourneau JG, Hunter DW, Ascher NL, Roberts JP, Payne WD, Thompson WM, Najarian JS, Castañeda-Zuñiga WR, and Day DL: Biliary complications in children after liver transplantation. Radiology 170: 3: Part 2: 1095-1099, 1989.
* 95. Gruber SA, Chavers B, Payne WD, Fryd DS, Canafax DM, Simmons RL, Najarian JS, and Matas JA: Allograft renal vascular thrombosis. Lack of increase with cyclosporine immunosuppression. Transplantation 47: 3: 475-478, 1989.
* 96. Stock PG, Estrin JA, Fryd DS, Payne WD, Belani KG, Elick BA, Najarian JS, and Ascher NL: Factors influencing early survival after liver transplantation. Am J Surg 157: 215-219, 1989.
97. Fischel RJ, Ascher NL, Payne WD, Freese DK, Stock PG, Fasola C, and Najarian JS: Pediatric liver transplantation across ABO blood group barriers. Transplant Proc 21: 1: 2221-2222, 1989.
98. Fryd DS, Kruse LVG, Simmons RL, Sutherland DER, Payne WD, and Najarian JS: Donor source, number of transplants, age at transplant, and diabetes: Risk factors in the cyclosporine era. Transplant Proc 21: 1: 1655-1656, 1989.
99. Stock PG, Payne WD, Ascher NL, Roberts JP, Belani K, Estrin J, and Najarian JS: Rapid infusion technique as a safe alternative to venovenous bypass in orthotopic liver transplant (TX). Transplant Proc 21: 1: 2322-2325, 1989.
100. Fasola CG, Fryd DS, Fischel RJ, Ascher NL, Payne WD, and Najarian JS: Adult kidney retransplantation: Evolution of treatment and results over 25 years at the University of Minnesota. Transplant Proc 21: 1: 2165-2167, 1989.
101. Gruber SA, Chavers B, Payne WD, Fryd DS, Canafax DM, Simons RL, Najarian JS, and Matas A: Frequency of allograft renal vascular thrombosis under three immunosuppressive regimens at a single institution. Transplant Proc 21: 1: 2139-2140, 1989.
102. Bumgardner GL, Mauer SM, Ascher NL, Payne WD, Dunn DL, Fryd DS, Sutherland DER, Simmons RL, and Najarian JS: Long-term outcome of renal transplantation in patients with systemic lupus erythematosus. Transplant Proc 21: 1: 2031-2032, 1989.
103. Bumgardner GL, Billiar T, So SK, Chen S, Dunn G, Payne W, and Ascher NL: In vitro immunosuppressive effects of murine hepatocyte cytosol. Transplant Proc 21: 1: 1154-1155, 1989.
* 104. Canafax DM, Min DI, Gruber SA, Fryd DS, Matas AJ, Payne WD, Dunn DL, Sutherland DER, Simmons RL, Najarian JS, and Fryd DS: Immunosuppression for cadaveric renal allograft recipients: A risk-factor matched comparison of the Minnesota randomized trial with an antilymphoblast globulin, azathioprine, cyclosporine, and prednisone protocol. Clin Transplantation 3: 110-119, 1989.
* 105. Bloomer JR, Weimer MK, Bossenmaier IC, Snover DC, Payne WD, and Ascher, NL: Liver transplantation in a patient with protoporphyria. Gastroenterology 97: 1: 188-194, 1989.
* 106. Gruessner RWG, Matas AJ, Lloveras G, Fryd DS, Dunn DL, Payne WD, Sutherland JDER, and Najarian JS: A comparison of single and double pediatric cadaver donor kidneys for transplantation. Clin Transplantation 3: 209-214, 1989.
* 107. Schwarzenberg SJ, Freese DK, Payne WD, Ascher NL, and Sharp HL: Case report: Gastric bezoar after hepatic transplantation. J Pediatr Gastroenterol Nutr 9: 1: 119-122, 1989.
* 108. Roberts JP, Ascher NL, Fryd DS, Hunter DW, Dunn DL, Payne WD, Sutherland DER, Castañeda-Zuñiga W, and Najarian JS: Transplant renal artery stenosis. Transplantation 48: 4: 580-583, 1989.
* 109. Tzardis PJ, Gruessner RWG, Matas AJ, Fryd DS, Payne WD, Dunn DL, Sutherland DER, and Najarian JS: Renal transplantation in patients with polycystic kidney disease: A single center experience. Clin Transplantation 3: 325-330, 1989.
* 110. Brayman KL, Morel P, Sutherland DER, Najarian JS, and Payne WD: Liver transplantation: Annotated references. Curr Opinion Immunol 1: 6: 1236-1240.
111. Matas AJ, Sutherland DER, Payne WD, Dunn DL, Perry E, and Najarian JS: New approaches to living donor renal transplantation. Minn Med 72: 589-592, 1989.
112. Bumgardner JGL, Ascher NL, Chen S, Cunningham TR, Payne WD, and Matas AJ: Immunosuppressive factor in hepatocyte and liver cytosol. Surg Forum 40: 391-393, 1989.
113. Fasola C, Matas A, Payne W, and Najarian J: Reversal of acute hepatic failure in a large animal by autologous hepatocyte transplantation. Surg Forum 40: 391-393, 1989.
* 114. Gruessner RWG, Matas AJ, Lloveras G, Fryd DS, Dunn DL, Payne WD, Sutherland DER, and Najarian JS: Pediatric donors - A risk factor in renal transplantation. Clin Transplantation 3: 349-354, 1989.
115. Estrin JA, Belani KG, Ascher NL, Lura D, Payne W, and Najarian JS: Hemodynamic changes on clamping and unclamping of major vessels during liver transplantation. Transplant Proc 21: 3: 3500-3505, 1989.
* 116. Bumgardner GL, Matas AJ, Chen S, Cahill D, Cunningham TR, Payne WD, Bach FH, and Ascher NL: Comparison of in vivo and in vitro immune response to purified hepatocytes. Transplantation 49: 2: 429-436, 1990.
117. Dunn DL, Schlumpf RB, Gruessner RWG, Morel P, Mayoral JL, Payne WD, Matas AJ, Sutherland DER, Moudry-Munns KC, and Najarian JS: Maximal use of liver and pancreas from cadaveric organ donors. Transplant Proc 22: 2: 423-424, 1990.
* 118. Letourneau JG, Hunter DW, Payne WD, and Day DL: Imaging and intervention in biliary complications after hepatic transplantation. AJR 154: 729-733, 1990.
* 119. Nakhleh RE, Schwarzenberg SJ, Bloomer J, Payne W, and Snover DC: The pathology of liver allografts surviving longer than one year. Hepatology 11: 3: 465-470, 1990.
120. Gruessner RWG, Matas AJ, Dunn JDL, Lloveras G, Payne WD, Sutherland DER, and Najarian JS: A comparison of pediatric versus adult cadaver donor kidneys for transplantation. Transplant Proc 22: 2: 361-362, 1990.
* 121. Pescovitz MD, Snover DC, Orchard P, Neglia JP, Najarian JS, and Payne WD: Primary hepatic lymphoma in an adolescent treated with hepatic lobectomy and chemotherapy. Cancer 65: 10: 2222-2226, 1990.
123. Schlumpf R, Morel P, Sutherland JD, Moudry-Munns K, Gruessner R, Payne W, and Dunn D: Combined procurement of pancreas and liver grafts does ot affect transplant outcome. Transplant Proc 22 4: 2074-2075, 1990.
* 124. Tzardis PJ, Gruessner RWG, Matas AJ, Payne WD, Dunn JDL, Sutherland DER, and Najarian JS: Long-term follow-up of renal transplantation for Wegener's Disease. Clin Transplantation 4: 2: 108-111, 1990.
* 125. Gruessner RWG, Tzardis PJ, Matas AJ, Dunn DL, Payne WD, Sutherland DER, and Najarian JS: Ileal and colon conduits in renal transplantation. Clin Transplantation 4: 3: 125-128, 1990.
* 126. Wrenshall LE, Matas AJ, Canafax DM, Min DI, Sibley RJ, Dunn DL, Payne WD, Sutherland JDER, and Najarian JS: An increased incidence of late acute rejection episodes in cadaver renal allograft recipients given azathioprine, cyclosporine, and prednisone. Transplantation 50: 2: 233-237, 1990.
* 127. Bumgardner GL, Chen S, Almond PS, Ascher NL, Payne WD, and Matas AJ: Role of macrophages in the immune response to hepatocytes. J Surg Res 48: 6: 568-572, 1990.
* 128. Matas AJ, Frey DJ, Gillingham KJ, Noreen HJ, Reinsmoen NL, Payne WD, Dunn DL, Sutherland DER, and Najarian JS: The impact of HLA matching on graft survival and on sensitization after a failed transplant - Evidence that failure of poorly matched renal transplants does not result in increased sensitization.
* 129. Tzardis PJ, Gruessner RWG, Matas AJ, Payne WD, Dunn DL, Sutherland DER, and Najarian JS: Fate of native polycystic kidneys left in situ after renal transplantation. Clin Transplantation 4: 5: 309-310, 1990.
130. Fasola CG, Kim YS, Manivel JC, Cerra FB, Matas AJ, and Payne WD: Reversal of acute hepatic failure in pigs by xenogeneic hepatocyte (HC) transplantation and by injection of supernatant from xenogeneic HC cultures. Surg Forum 41: 374-376, 1990.
* 131. Almond PS, Bumgardner JGL, Chen S, Cunningham BS, Payne WD, and Matas AJ: Correlation of class I antigen expression with immunogenicity. Curr Surgery 47: 4: 262-264, 1990.
* 132. Bumgardner GL, Matas AJ, Payne WD, Dunn DL, Sutherland DER, and Najarian JS: Renal transplantation in patients with paraproteinemias. Clin Transplantation 4: 6: 399-405, 1990.
* 133. Stock PG, and Payne WD: Liver transplantation. Crit Care Clin 6: 4: 911-926, 1990.
* 134. Brayman KL, Vianello A, Morel P, Payne WD, Sutherland DER: The organ donor. Crit Care Clin 6: 4: 821-839, 1990.
* 135. Dunn DL, Mayoral JL, Gillingham KJ, Loeffler CM, Brayman KL, Kramer MA, Erice A, Balfour HH Jr. Fletcher JCV, Bolman RM, III, Matas AJ, Payne WD, Sutherland DER, and Najarian JS: Treatment of invasive cytomegalovirus disease in solid organ transplant patients with ganciclovir. Transplantation 51: 1: 98-106, 1991.
* 136. Fischel RJ, Payne WD, Gillingham KJ, Dunn DL, Sutherland DER, Matas AJ, and Najarian JS: Long-term outlook for renal transplant recipients with one-year function: "Doctor, what are my chances?" Transplantation 51: 1: 118-122, 1991
* 137. Dunn DL, Morel P, Schlumpf R, Mayoral JL, Gillingham KJ, Moudry-Munns KC, Krom RAF, Gruessner RWG, Payne WD, Sutherland DER, and Najarian JS: Evidence that combined procurement of pancreas and liver grafts does not affect transplant outcome. Transplantation 51: 1: 150-157, 1991.
138. Morel P, Gillingham KJ, Schlumpf R, Chau C, Moudry-Munns K, Payne WD, Najarian JS, Sutherland DER, and Dunn DL: Effect of simultaneous liver retrieval, retrieval team, and preservation time on cadaver whole-organ, bladder-drained pancreatic allograft survival rates. Transplant Proc 23: 1: 1640-1642, 1991.
139. Fasola CG, Kim YS, Morel P, Dunn DL, Sutherland DER, Payne WD, Matas AJ, and Najarian JS: Kidney retransplantation: Patients with a failed second kidney transplant should be considered for a third transplant. Transplant Proc 23: 1: 1336, 1991.
* 140. Morel P, Almond PS, Matas AJ, Gillingham KJ, Chau C, Brown A, Kashtan CE, Mauer SM, Chavers B, Nevins TE, Dunn DL, Sutherland DER, Payne WD, and Najarian JS: Long-term quality of life after kidney transplantation in childhood. Transplantation 52: 1: 47-53, 1991.
141. Almond PS, Morel P, Matas AJ, Gillingham KJ, Chau KS, Brown A, Kashtan CE, Mauer SM, Chavers B, Nevins TE, Dunn DL, Sutherland DER, Payne WD, and Najarian JS: Transplanted children with long-term graft function have an excellent quality of life. Transplant Proc 23: 1: 1380-1381, 1991.
142. Troppmann C, Almond PS, Escobar FS, Morel P, Papalois AE, Dunn DL, Payne WD, Sutherland JDER, Matas AJ, and Najarian JS: Donor age and cause of death affect cadaver renal allograft outcome. Transplant Proc 23: 1: 1365-1366, 1991.
143. Fischel RJ, Matas AJ, Payne WD, Gillingham KJ, Dunn DL, Sutherland DER, and Najarian JS: Long-term outcome in 1-year graft survivors: Comparison of diabetic and nondiabetic populations. Transplant Proc 23: 1: 1337, 1991.
144. Almond PS, Bumgardner GL, Chen S, Platt J, Payne WD, and Matas AJ: Immunogenicity of class I+, class II-hepatocytes. Transplant Proc 23: 1: 108-109, 1991.
145. Frey DJ, Matas AJ, Gillingham KJ, Canafax D, Payne WD, Dunn DL, Sutherland DER, and Najarian JS: MALG vs OKT3 following renal transplantation: A randomized prospective trial. Transplant Proc 23: 1: 1048-1049, 1991.
* 146. Almond PS, Matas AJ, Gillingham K, Troppmann C, Payne W, Dun D, Sutherland D, and Najarian JS: Risk factors for second renal allografts immunosuppressed with cyclosporine. Transplantation 52: 2: 253-258, 1991.
* 147. Freese DK, Snover DC, Sharp HL, Gross CR, Savick SK, and Payne WD: Chronic rejection after liver transplantation: A study of clinical, histopathologic, and immunologic features. Hepatology 13: 5: 882-891, 1991.
148. Aeder MI, Fasola CG, Dunning M, Payne WD, Dunn DL, Najarian JS, and Sutherland DER: Successful canine small intestinal allotransplantation: Ex vivo irradiation and cyclosporine pretreatment. Transplant Proc 23: 1: 685-687, 1991.
* 149. Schweitzer EJ, Matas AJ, Gillingham KJ, Payne WD, Gores PF, Dunn DL, Sutherland DER, and Najarian JS: Causes of renal allograft loss: Progress in the 1980's, challenges for the 1990's. Ann Surg 214: 6: 679-688, 1991.
* 150. Rank JM, Pascual-Leone A, Payne W, Glock M, Freese D, Sharp H. Bloomer JR: Hematin therapy in the neurologic crisis of tyrosinemia. J Pediatr 118: 136-139, 1991.
* 151. Yedlicka JW, Halloran J, Payne WD, Hunter DW, Castañeda-Zuñiga WR, Amplatz K, and Letourneau JG: Angiogenesis after hepatic arterial occlusion in liver transplant patients. J Vasc Interven Radiology 2: 2: 235-240, 1991.
* 152. Morel P, Troppmann C, Almond PS, Schlumpf R, Gillingham KJ, Sutherland DER, Dunn DL, Payne WD, Matas AJ, and Najarian JS: Multiorgan procurement does not affect the immediate outcome of kidney transplants. Clin Transplantation 5: 381-385, 1991.
* 153. Freese DK, Tuchman M, Schwarzenberg SJ, Sharp HL, Rank JM, Bloomer JR, Ascher NL, and Payne WD: Early liver transplantation is indicated for tyrosinemia Type I. J Pediatr Gastroenterol Nutr 13: 10-15, 1991.
154. Shatford RA, Nyberg SL, Payne WD, Hu W-S, Cerra FB: A hematocyte bioreactor as a potential bioartificial liver: Demonstration of prolonged tissue specific functions. Surg Forum 42: 54-56, 1991.
* 155. Fasola CG, Kim YS, Aeder MI, Dunning M, Müller T, Nakhleh RE, Almond S, Payne WD, and Dunn DL: Pretransplant immunotherapy can prolong function of small bowel allografts in dogs. Curr Surg 48: 469-473, 1991.
* 156. Brayman KL, Stephanian E, Matas AJ, Schmidt W, Payne WD, Sutherland DER, Gores PF, Najarian JS, and Dunn DL: Analysis of infectious complications occurring after solid-organ transplantation. Arch Surg 127: 38-48, 1992.
* 157. Almond PS, Matas AJ, Gillingham K, Moss A, Mauer M, Chavers B, Nevins T, Kashtan C, Dunn D, Payne W, Sutherland D, Gores P, and Najarian JS: Pediatric renal transplants - Results with sequential immunosuppression. Transplantation 53: 1: 46-51, 1992.
* 158. Almond PS, Gillingham KJ, Sibley R, Moss A, Melin M, Leventhal J, Manivel C, Kyriakides P, Payne WD, Dunn DL, Sutherland DER, Gores PF, Najarian JS, and Matas AJ: Renal transplant function after ten years of cyclosporine. Transplantation 53: 2: 316-323, 1992.
* 159. Matas AJ, Payne WD, Gillingham KJ, Dunn DL, Sutherland DER, and Najarian JS: Optimizing the immediate posttransplant prednisone dose - A prospective randomized trial. Clin Transplantation 6: 73-76, 1992.
* 160. Nyberg SL, Shatford RA, Hu W-S, Payne WD, and Cerra FB: Hepatocyte culture systems for artificial liver support: Implications for critical care medicine (bioartificial liver support). Crit Care Med 20: 8: 1157-1168, 1992.
* 161. Frey DJ, Matas AJ, Gillingham KJ, Canafax D, Payne WD, Dunn DL, Sutherland DER, and Najarian JS: Sequential therapy - A prospective randomized trial of MALG versus OT3 for prophylactic immunosuppression in cadaver renal allograft recipients. Transplantation 54: 1: 50-56, 1992.
162. Nyberg SL, Platt JL, Shirabe K, Payne WD, Hu W-S, and Cerra FB: Immunoprotection of xenocytes in a hollow fiber bioartificial liver. ASAIO J 38: M463-M467, 1992.
* 163. Shatford RA, Nyberg SL, Meier SJ, White JG, Payne WD, Hu W-S, and Cerra FB: Hepatocyte function in a hollow fiber bioreactor: A potential bioartificial liver. J Surg Res 53: 549-557, 1992.
* 164. Dunn DL, Mayoral JL, Gillingham KJ, Sawyer MD, Kramer MA, Statz CL, McHugh L, Matas AJ, Gores PF, Payne WD, Sutherland DER, and Najarian JS: Simultaneous treatment of concurrent rejection and tissue invasive cytomegalovirus disease without detrimental effects upon patient or allograft survival. Clin Transplantation 6: 413-420, 1992.
* 165. Nyber SL, Shatford RA, Payne WD, Hu W-S, and Cerra FB: Primary culture of rat hepatocytes entrapped in cylindrical collagen gels: An in vitro system with application to the bioartificial liver. Cytotechnology 10: 205-216, 1993.
* 166. Nyberg SL, Shatford RA, Payne WD, Hu W-S, and Cerra FB: Staining with fluorescein diacetate correlates with hepatocyte function. Biotechnic Histochem 68: 1: 56-63, 1993.
* 167. Santilli SM, Payne WD, Hunter DW, Knighton DR: Comparison of preoperative standard angiography with preoperative balloon occlusion femoral angiography of the lower extremity. J Invest Surg 6: 83-95, 1993.
168. Troppmann C, Almond PS, Payne WD, Dunn DL, Gores PF, Gruessner RWG, Sutherland DER, Matas AJ, and Najarian JS: Does acute tubular necrosis affect renal transplant outcome? The impact of rejection episodes. Transplant Proc 25: 1: 905, 1993.
169. Basadonna GP, Matas AJ, Gillingham KJ, Payne WD, Dunn DL, Sutherland DER, Gores PF, Gruessner RWG, Arrazola L, and Najarian JS: Relationship between early vs late acute rejection and onset of chronic rejection in kidney transplantation. Transplant Proc 25: 1: 910-911, 1993.
170. Almond PS, Matas AJ, Gillingham K, Dunn DL, Payne WD, Gores P, Gruessner R, and Najarian JS: Predictors of chronic rejection in renal transplant recipients. Transplant Proc 25: 1: 936, 1993.
171. Jones JW, Matas AJ, Gillingham KJ, Gores PF, Payne WD, Gruessner RF, Sutherland DER, and Najarian JS: Employment and disability after renal transplantation. Transplant Proc 25: 1: 1368, 1993.
172. Kaufman DB, Matas AJ, Arrazola L, Gillingham KJ, Sutherland DER, Payne WD, Dunn DL, Gores PF, and Najarian JS: Transplantation of kidneys from zero haplotype-matched living donors and from distantly related and unrelated donors in the cyclosporine era. Transplant Proc 25: 1: 1530-1531, 1993.
173. Fasola CG, Kim YS, Dunning M, Condie RM, Kurle J, Manivel JC, Nakhleh RE, Schlumpf R, Payne WD, Sutherland DER, Najarian JS, and Dunn DL: Successful canine small bowel preservation in simple cod storage for 48 hours using a Dextran-40 based solution. Transplant Proc 25: 1: 1576-1579, 1993.
174. Canafax DM, Carleton BC, Matas AJ, Payne WD, Dunn DL, Sutherland DER, and Najarian JS: Effects of three immunosuppressive drug protocols on cadaver renal transplantation costs after 4 years of therapy. Transplant Proc 25: 1: 1692-1693, 1993.
175. Nyberg SL, Payne WD, Amiot B. Shirabe K, Remmel RP, Hu W-S, and Cerra FB: Demonstration of biochemical function by extracorporeal xeno-hepatocytes in an anhepatic animal model. Transplant Proc 25: 2: 1944-1945, 1993.
* 176. Schwarzenberg SJ, Freese DK, Regelmann WE, Gores PF, Boudreau FJ, and Payne WD: Resolution of severe intrapulmonary shunting after liver transplantation. Chest 103: 4: 1271-1273, 1993.
* 177. Almond PS, Matas A, Gillingham K, Dunn DL, Payne WD, Gores P, Gruessner R, and Najarian JS: Risk factors for chronic rejection in renal allograft recipients. Transplantation 55: 752-757, 1993.
* 178. Basadonna GP, Matas AJ, Gillingham KJ, Payne WD, Dunn DL, Sutherland DER, Gores PF, Gruessner RWG, and Najarian JS: Early versus late acute renal allograft rejection: Impact on chronic rejection. Transplantation 55: 993-995, 1993.
179. Jones JW, Payne WD, and Matas AJ: The living donor - risks, benefits, and related concerns. Transplant Reviews 7: 115-128, 1993.
* 180. Nyberg SL, Shirabe K, Peshwa MV, Sielaff TD, Crotty PL, Mann HJ, Remmel RP, Payne WD, Hu W-S, and Cerra FB: Extracorporeal application of a gel-entrapment, bioartificial liver: Demonstration of drug metabolism and other biochemical functions. Cell Transplantation 2: 441-452, 1993.
* 181. Nyberg SL, Peshwa MV, Payne WD, Hu W-S, and Cerra FB: Evolution of the bioartificial liver: The need for randomized clinical trials. Am J Surg 166: 512-521, 1993.
* 182. Jones JW Jr, Gillingham KJ, Sutherland DER, Payne WD, Dunn DL, Gores PF, Gruessner RWG, Najarian JS, Matas AJ: Successful long-term outcome with 0-haplotype-matched living-related kidney donors. Transplantation 57: 512-515, 1994.
* 183. Dunn DL, Gillingham KJ, Kramer MA, Schmidt WJ, Erice A, Balfour HH, Gore PF, Gruessner RWG, Matas AJ, Payne WD, Sutherland DER, and Najarian JS: A prospective randomized study of acyclovir versus ganciclovir plus human immune globulin prophylaxis of cytomegalovirus infection after solid organ transplantation. Transplantation 57: 876-884, 1994.
* 184. Najarian JS, Gillingham KJ, Sutherland DER, Reinsmoen NL, Payne WD, and Matas AJ: The impact of the quality of initial graft function on cadaver kidney transplants. Transplantation 57: 812-816, 1994.
* 185. Matas AJ, Gillingham KJ, Payne WD, and Najarian JS: The impact of an acute rejection episode on long-term renal allograft survival (t1;2). Transplantation 57: 857-859, 1994.
* 186. Santilli SM, Stevens RB, Anderson JD, Payne WD, and Caldwell MD: The transarterial wall oxygen gradient at the dog carotid bifurcation. Am J Physiol 268 (Heart Circ Physiol 37): H155-H11, 1995.
* 187. Troppmann C, Benedetti E, Gruessner RWG, Payne WD, Sutherland DER, Najarian JS and Matas AJ: Retransplantation after renal allograft loss due to noncompliance: Indications, outcome, and ethical concerns. Transplantation 59: 467-471, 1995.
188. Payne WD: The rational development of liver allocation policy. Liver Transplantation and Surgery 1: 58-61, 1995.
* 189. Benedetti E, Pirenne J, Troppmann C, Hakim N, Gruessner JR, Cochrane JR, Irmiter R, Payne W, and Belani K: A percutaneous technique for venous return cannula insertion for venovenous bypass in hepatic transplantation. Transplantation 59: 789-791, 1995.
* 190. Shirabe K, Kin S, Shinagawa Y, Chen S, Payne WD, and Sugimachi K: Inhibition of thromboxane A2 activity during warm ischemia of the liver. J Surg Res 61: 1: 103-107, 1996.
* 191. Matas AJ, Lawson W, McHugh L, Gillingham K, Payne WD, Dunn DL, Gruessner RWG, Sutherland DER, and Najarian JS: Employment patterns after successful kidney transplantation. Transplantation 61: 5: 729-733, 1996.
192. Bloomer JR, Rank JM, Payne WD, Snover DC, Sharp HL, Zwiener RJ, and Carithers RL: Follow-up after liver transplantation for protoporphyric liver disease. Liver Transplant & Surg 2: 4: 269-275, 1996.
* 193. Nyberg SL, Mann HJ, Hu MY, Payne WD, Hu W-S, Cerra FB, and Remmel RP: Extrahepatic metabolism of 4-methylumbelliferone and lidocaine in the anhepatic rabbit. Drug Metab Dispos 24: 6: 643-648, 1996.
* 194. Troppmann C, Gillingham KJ, Gruessner RWG, Dunn DL, Payne WD, Najarian JS and Matas AJ: Delayed graft function in the absence of rejection has no long-term impact. A study of cadaver kidney recipients with good graft function at 1 year after transplantation. Transplantation 61: 9: 1331-1337, 1996.
* 195. Benedetti E, Pirenne J, Troppmann C, Hakim N, Moon C, Gruessner RWG, Sharp H, Matas AJ, Payne WD, and Najarian JS: Combined liver and kidney transplantation. Transplant Int. 9: 5: 486-491, 1996.
* 196. Matas AJ, Gillingham KJ, Payne WD, Dunn DL, Gruessner RWG, Sutherland DER, Schmidt W, and Najarian JS: A third kidney transplant: Cost-effective treatment for end-sage renal disease? Clin Transplantation 10: (6 Pt 1): 516-520, 1996.
* 197. Matas AJ, Gillingham KJ, Chavers BM, Nevins T, Kashtan C, Mauer SM, Payne WD, Gruessner RWG, and Najarian JS: The importance of early cyclosporine levels in pediatric kidney transplantation. Clin Transplantation 10: (6 Pt 1): 482-486, 1996.
* 198. Lederle FA, Johnson GR, Wilson SE, Gordon IL, Chute EP, Littooy FN, Krupski WC, Bandyk D, Barone GW, Graham LM, Hye RJ, Reinke DB, and the Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Investigators: Relationship of age, gender, race, and body size to infrarenal aortic diameter. J Vasc Surg 26: 595-601, 1997.
* 199. Matas AJ, Gillingham KJ, Elick BA, Dunn DL, Gruessner RWG, Payne WD, Sutherland DER, and Najarian JS: Risk factors for prolonged hospitalization after kidney transplants. Clin Transplantation 11: 4: 259-264, 1997.
* 200. Humar A, Johnson EM, Payne WD, Wrenshall L, Sutherland DER, Najarian JS, Gillingham KJ, and Matas AJ: Effect of initial slow grft function on renal allograft rejection and survival. Clin Transplantation 11: 6: 623-627, 1997.
* 201. Humar A, Johnson EM, Gillingham KJ, Sutherland DER, Payne WD, Dunn DL, Wrenshall LE, Najarian JS, Gruessner RWG, and Matas AJ: Venous thromboembolic complications after kidney and kidney-pancreas transplantation: A multivariate analysis. Transplantation 65: 2: 229-234, 1998.
* 202. Santilli SM, Kronson JW, and Payne WD: Cigarette smoking alters the rabbit transarterial wall oxygen gradient. Ann Vasc Surg 12: 2: 174-181, 1998.
* 203. Farney AC, Gamboa P, Payne WD, and Gruessner RWG: Donor iliac vein interposition during liver transplantation in a patient with a migrated transjugular intrahepatic portosystemic shunt. Transplantation 65: 4: 572-574, 1998.
* 204. Santilli SM, Kronson J, and Payne WD: The effect of hypercholesterolemia on the rabbit transarterial wall oxygen gradient. Ann Vasc Surg 12: 5: 418-423, 1998.
* 205. Humar A, Johnson EM, Payne WD, Dunn DL, Wrenshall LE, Najarian JS, Gruessner RWG, and Matas AJ: The acutely ischemic extremity after kidney transplant: An approach to management. Surgery 123: 3: 344-350, 1998.
* 206. Matas AJ, McHugh L, Payne WD, Wrenshall LE, Dunn DL, Gruessner RWG, Sutherland DER, and Najarian JS: Long-term quality of life after kidney and simultaneous pancreas-kidney transplantation. Clin Transplantation 12: 3: 233-242, 1998.
* 207. Hakim NS, Kobienia B, Benedetti E, Bloomer J, and Payne WD: Methotrexate-induced hepatic necrosis requiring liver transplantation in a patient with rheumatoid arthritis. Int Surgery 83: 3: 224-225, 1998.
* 208. Beebe DS, Pena A, Payne W, and Belani KG: Double volume exchange transfusion for ABO incompatible liver transplantation in paediatric patients: Intraoperative and preoperative approach. Paediatric Anaesthesia 8: 3: 205-210, 1998.
* 209. Hakim NS, Benedetti E, Payne WD, Gruessner RWG, Gores P, Sutherland DER, Najarian JS and Matas AJ: Pre-emptive renal transplantation. Int Surgery 83: 4: 330-332, 1998.
* 210. Humar A, Mauer M, Durand B, Payne W, Sharp H, and Gruessner R: Kidney and liver transplantation from living related and cadaver donors for primary hyperoxaluria type 1. Proceedings of the Third International Congress of Pediatric Transplantation (Supplement) 2: 1: 47, 1998.
* 211. Humar A, Sharp H, Payne W, Walsh J, and Gruessner R: Preoperative radiologic assessment of living related liver donors. Proceedings of the Third International Congress of Pediatric Transplantation 2: 1: 54, 1998.
* 212. Matas AJ, Humar A, Payne WD, Gillingham KJ, Dunn DL, Sutherland DER, and Najarian JS: Decreased acute rejection in kidney transplant recipients is associated with decreased chronic rejection. Ann Surg 230: 4: 493-498, 1999.
* 213. Nagao K, Beebe DS, Nguyen C, Payne WD, Sharp HL, and Belani KG: Perioperative mortality after pediatric liver transplantation. J Anaesth Clin Pharmacol 15: 3: 299-305, 1999.
* 214. Humar A, Hassoun A, Kandaswamy R, Payne WD, Sutherland DE, and Matas AJ. Immunologic factors -- The major risk for decreased long-term renal allograft survival. Transplantation 68: 12: 1842-1846, 1999.
* 215. Humar A, Gillingham KJ, Payne WD, Dunn DL, Sutherland DE, and Matas AJ: Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients. Transplantation 68: 12: 1879-1883, 1999.
* 216. Matas AJ, Gillingham K, Payne WD, Humar A, Dunn DL, Sutherland DE, and Najarian JS: Should I accept this kidney? Clin Transplantation 14: 1: 90-95, 2000.
* 217. Humar A, Durand B, Gillingham K, Payne WD, Sutherland DE, and Matas AJ: Living unrelated donors in kidney transplants: Better long-term results than non-HLA identical living related donors? Transplantation 69: 9: 1942-1945, 2000.
* 218. Humar A, Payne WD, Sutherland DER, and Matas AJ: Clinical determinants of multiple acute rejection episodes in kidney transplant recipients. Transplantation 69: 11: 2357-2360, 2000.
* 219. Humar A, Gillingham K, Payne WD, Sutherland DER, and Matas AJ: Increased incidence of cardiac complications in kidney transplant recipients with cytomegalovirus disease. Transplantation 70: 2: 310-313, 2000.
* 220. Humar A, Key N, Ramcharan T, Payne WD, Sutherland DER, Matas AJ: Kidney retransplants after initial graft loss to vascular thrombosis. Clin Transplantation 15: 1: 6-10, 2001.
* 221. Kandaswamy R, Gillingham K, Humar A, Payne WD, Dunn DL, Sutherland DE, Najarian JS, Matas AJ. Impact of HLA-ABDR match on chronic rejection in kidney transplants. Transplant Proc 33: 1-2: 1292, 2001.
* 222. Kandaswamy R, Sutherland DE, Humar A, Payne WD, Gruessner RW, Matas AJ. Transplantation without a final crossmatch - it can be done. Transplant Proc 33: 1-2: 1234, 2001.
* 223. Kandaswamy R, Humar A, Payne WD, Dunn DL, Sutherland DE, Matas AJ. Risk factors for kidney transplant acute rejection: a multivariate analysis. Transplant Proc 33: 102: 1112, 2001.
* 224. Arrazola L, Sutherland DE, Sozen H, Hunter DW, Payne WD, Najarian JS, Matas AJ. May-Thurner syndrome in renal transplantation. Transplantation 71: 5: 698-702, 2001.
* 225. Nath KA, Vercellotti G, Grande JP, Miyoshi H, Paya C, Namival JC, Haggard JJ, Croatt AJ, Payne W, and Alam J: Heme protein-induced chronic renal inflammation: Suppressive effect of induced heme oxygenase-1. Kid Int 59: 1: 106-117, 2001.
* 226. Payne WD: Proposing change in organ allocation. (Editorial). Liver Transplantation, 7: 3: 179-180, 2001.
* 227. Humar A, Lake JR, Payne WD, Ramcharan T. Outcome of other organs recovered during in situ split-liver procurements. Accepted for publication in Liver Transplant.
* 228. Humar A, Ramcharan T, Gillingham KJ, Payne WD, Matas A. Ar wound complications after kidney transplant more common with modern immunosuppression? Accepted for Transplantation.
* 229. Humar A, Kandaswamy R, Sielaff T, Gruessner R, Lake J, Payne WD: Split liver transplantation for 2 adult recipients: An initial experience. Submitted to American Journal of Transplantation, 2001.
* 229. Humar A, Mauer M, Durand B, Payne W, Sharp H, Gruessner R: Kidney and liver transplantation from living related and cadaver donors for primary hyperoxaluria type 1. Proceedings of the Third International Congress of Pediatric Transplantation. 1998;2(1 Supplement)47.
* 230. Humar A, Sharp H, Payne W, Walsh J, Gruessner R: Preoperative radiologic assessment of living related liver donors. Proceedings of the Third International Congress of Pediatric Transplantation. 1998;2(1):54.
* 231. Matas AJ, Humar A, Payne WD, Gillingham KJ, Dunn DL, Sutherland DE, Najarian JS: Decreased acute rejection in kidney transplant recipients is associated with decreased chronic rejection. Ann Surg. 1999 Oct;230(4):493-8; discussion 498-500.
* 232. Nagao K, Beebe DS, Nguyen C, Payne WD, Sharp HL, Belani KG: Perioperative mortality after pediatric liver transplantation. J Anaesth Clin Pharmacol. 1999;15(3):299-305.
* 233. Humar A, Hassoun A, Kandaswamy R, Payne WD, Sutherland DE, Matas AJ: Immunologic factors: the major risk for decreased long-term renal allograft survival. Transplantation. 1999 Dec 27;68(12):1842-6.
* 234. Humar A, Gillingham KJ, Payne WD, Dunn DL, Sutherland DE, Matas AJ: Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients. Transplantation. 1999 Dec 27;68(12):1879-83.
* 235. Matas AJ, Gillingham K, Payne WD, Humar A, Dunn DL, Sutherland DE, Najarian JS: Should I accept this kidney? Clin Transplant. 2000 Feb;14(1):90-5.
* 236. Humar A, Durand B, Gillingham K, Payne WD, Sutherland DE, Matas AJ: Living unrelated donors in kidney transplants: better long-term results than with non-HLA- identical living related donors? Transplantation. 2000 May 15;69(9):1942-5.
* 237. Humar A, Payne WD, Sutherland DE, Matas AJ: Clinical determinants of multiple acute rejection episodes in kidney transplant recipients. Transplantation. 2000 June 15;69(11):2357-60.
* 238. Humar A, Gillingham K, Payne WD, Sutherland DE, Matas AJ: Increased incidence of cardiac complications in kidney transplant recipients with cytomegalovirus disease. Transplantation. 2000 July 27;70(2):310-3.
* 239. Humar A, Key N, Ramcharan T, Payne WD, Sutherland DE, Matas AJ: Kidney retransplants after initial graft loss to vascular thrombosis. Clin Transplant. 2001 Feb;15(1):6-10.
* 240. Kandaswamy R, Gillingham K, Humar A, Payne WD, Dunn DL, Sutherland DE, Najarian JS, Matas AJ: Impact of HLA-ABDR match on chronic rejection in kidney transplants. Transplant Proc. 2001 Feb-Mar;33(1-2):1292.
* 241 Kandaswamy R, Sutherland DE, Humar A, Payne WD, Gruessner RW, Matas AJ: Transplantation without a final crossmatch – it can be done. Transplant Proc. 2001 Feb-Mar;33(1-2):1234.
* 242. Kandaswamy R, Humar A, Payne WD, Dunn DL, Sutherland DE, Matas AJ: Risk factors for kidney transplant acute rejection: a multivariate analysis. Transplant Proc. 2001 Feb-Mar;33(1-2):1112.
* 243. Arrazola L, Sutherland DE, Sozen H, Hunter DW, Payne WD, Najarian JS, Matas AJ: May-Thurner syndrome in renal transplantation. Transplantation. 2001 Mar 15;71(5):698-702.
* 244. Nath KA, Vercellotti G, Grande JP, Miyoshi H, Paya C, Manival JC, Haggard JJ, Croatt AJ, Payne W, Alam J: Heme protein-induced chronic renal inflammation: Suppressive effect of induced heme oxygenase-1. [see comments.] Kidney Int 59:1:106-117, 2001.
* 245. Payne WD: Proposing change in organ allocation. Liver Transpl. 2001 Mar;7(3):179-80.
* 246. Ramcharan T, Glessing, Lake JR, Payne WD, Humar A: Outcome of other organs recovered during in situ split-liver procurements. Liver Transpl. 2001; Oct; 7(10):853-7.
* 247. Humar A, Ramcharan T, Denny R. Gillingham KJ, Payne WD, Matas A: Are wound complications after kidney transplant more common with modern immunosuppression? Transplantation. 2001 Dec 27;72(12):1920-3.
* 248. Matas AJ, Humar A, Kandaswamy R, Payne WD, Gruessner RW, Sutherland DE: Kidney and pancreas transplantation without a crossmatch in select circumstances–it can be done. Clin Transplant. 2001 Aug;15(4):236-9.
* 249. Moss A, Najarian JS, Sutherland DE, Payne WD, Gruessner RW, Humar A, Kandaswamy R, Gillingham KJ, Dunn DL, Matas AJ: 5,000 kidney transplants—a single-center experience. Clinical Transpl. 2000; :59-71.
* 250. Matas AJ, Payne WD, Sutherland DE, Humar A, Gruessner RW, Kandaswamy R, Dunn DL, Gillingham KJ, Najarian JS: 2,500 Living donor kidney transplants: a single-center experience. Ann Surg. 2001;234(2):149-64.
* 251. Matas AJ, Ramcharan T, Paraskevas S, Gillingham KJ, Dunn DL, Gruessner RW, Humar A, Kandaswamy R, Najarian JS, Payne WD, Sutherland DE: Rapid discontinuation of steroids in living donor kidney transplantation: a pilot study. Am J Transplant. 2001 Sep;1(3):278-3.
* 252. Humar A, Ramcharan T, Sielaff TD, Kandaswamy R, Gruessner RW, Lake JR, Payne WD: Split liver transplantation for two adult recipients: an initial experience. Amer J. Transplantat. 2001 Nov;1(4):366-72.
* 253. Ramcharan T, Glessing B, Lake JR, Payne WD, Humar A: Outcome of other organs recovered during in situ split-liver procurements. Liver Transplantation. 7: 10: 853-7, 2001.
* 254. Matas AJ, Humar A, Gillingham KJ, Payne WD, Gruessner RW, Kandaswamy R, Dunn DL, Najarian JS, Sutherland DE: Five preventable causes of kidney graft loss in the 1990s: a single-center analysis. Kidney Int. 2002 Aug;62(2):704-14.
* 255. Schwarzenberg, SJ, Sharp HL, Payne, WD, Hunter DW, Bjarnason H, Humar A, Weisdorf-Schindele SA, Gruessner RW: Biliary stricture in living-related donor liver transplantation: management with balloon dilation. Pediatr Transplant. 2002 Apr;6(2): 132-5.
* 256. Bostom AD, Brown RS Jr, Chavers BM, Coffman TM, Cosio FG, Culver K, Curtis JJ, Danovitch GM, Everson GT, First MR, Garvey C, Grimm R, Hertz MI, Hricik DE, Hunsicker LG, Ibrahim H, Kasiske BL, Kennedy M, Klag M, Knatterud ME, Kobashigawa J, Lake JR, Light JA, Matas AJ, McDiarmid SV, Miller LW, Payne WD, Rosenson R, Sutherland DE, Tejani A, Textor S, Valantine HA, Wiesner RH: Prevention of post-transplant cardiovascular disease – report and recommendations of an ad hoc group. Am J. Transplant. 2002 Jul;2(2):491-500.
* 257. Humar A, Khwaja K, Sielaff TD, Lake JR, Payne WD: Technique of split-liver transplant for two adult recipients. Liver Transpl. 2002 Aug;8(8):725-9.
* 258. Humar A, Ramcharan T, Kandaswamy R, Gillingham K, Payne WD, Matas AJ:. Risk factors for slow graft function after kidney transplants: a multivariate analysis. Clin Transplant. 2002 Dec;16(6):425-9.
* 259. Paraskevas S, Kandaswamy R, Humar A, Gillingham K, Gruessner RW, Payne WD, Najarian JS, Dunn DL, Sutherland DE, Matas AJ:. Predicting long-term kidney graft survival: can new trials be performed? Transplantation. 2003 Apr 27;75(8):1256-9.
* 260. Humar A, Khwaja K, Sielaff T, Lake J, Payne WD: Split-liver transplants for two adult recipients: technique of preservation of the vena cava with the right lobe graft. Liver Transpl. 2004 Jan;10(1):153-5.
* 261. Humar A, Kosari K, Sielaff TD, Glessing B, Gomes M, Dietz C, Rosen G, Lake J, Payne WD: Liver regeneration after adult living donor and deceased split-liver transplants. Liver Transpl. 2004 Mar;10:(3):374-8.
* 262. Weiss CA 3rd, Payne WD, Sielaff TD. Management of an occluded Wallstent for a benign biliary stricture: a case report. Hepatogastroenterology. 2004 Mar-Apr 51(56):378-380.
* 263. Humar A, Khwaja K, Glessing B, Larson E, Asolati M, Durand B, Lake J, Payne WD. Regionwide sharing for status 1 liver patients – beneficial impact on waiting time and pre- and posttransplant survival. Liver Transpl. 2004 May;10(5):661-5.
* 264. Krabbenhoft DM, Hoang CD, Morris A, Hunter DW, Payne WD, Dunn DL, Bullard KM: Complications of chronic pelvic radiation injury. J Am Coll Surg. 2004 Jun;198(6):1022-3.
* 265. Khwaja K, Asolati M, Harmon J, Melancon JK, Dunn T, Gillingham K, Kandaswamy R, Humar A, Gruessner R, Payne W, Najarian J, Dunn D, Sutherland D, Matas AJ: Outcome at 3 years with a prednisone-free maintenance regimen: a single-center experience with 349 kidney transplant recipients. Am J Transplant. 2004 Jun; 4(6):980-7.
* 266. Matas AJ, Kandaswamy R, Humar A, Payne WD, Dunn DL, Najarian JS, Gruessner RW, Gillingham KJ, McHugh LE, Sutherland DE: Long-term immunosuppression, without maintenance prednisone, after kidney transplantation. Ann Surg. 2004 Sep;240(3):510-6; discussion 516-7.
* 267. Khwaja K, Asolati M, Harmon JV, Melancon JK, Dunn TB, Gillingham KJ, Kandaswamy R, Humar A, Gruessner RW, Payne WD, Najarian JS, Dunn DL, Sutherland DE, Matas AJ: Rapid discontinuation of prednisone in higher-risk kidney transplant recipients. Transplantation. 2004 Nov 15;78(9):1397-9.
* 268. Humar A, Horn K, Kalis A, GlessingB, Payne WD, Lake J: Living donor and split-liver transplants in hepatitis C recipients; does liver regeneration increase the risk for recurrence? Am J Transplant. 2005 Feb;5(2):399-405.
* 269. Humar A, Carolan E, Ibrahim H, Horn K, Larson E, Glessing B, Kandaswamy R, Gruessner RW, Lake J, Payne WD: A comparison of surgical outcomes and quality of life surveys in right lobe vs. left lateral segment liver donors. Am J Transplant. 2005 Apr; 5(4 Part 1):805-9.
* 270. Kandaswamy R, Melancon JK, Dunn T, Tan M, Casingal V, Humar A, Payne WD, Gruessner RW, Dunn DL, Najarian JS, Sutherland DE, Gillingham KJ, Matas A: A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients--an interim analysis. Am J Transplant. 2005 Jun;5(6):1529-36.
* 271. Daniels JA, Coad JE, Payne WD, Kosari K, Sielaff TD: Biliary cystadenomas: hormone receptor expression and clinical management. Dig Dis Sci. 2006 Mar;51(3):623-8
* 272. Nath DS, Kalis A, Nelson S, Payne WD, Lake JR, Humar A: Hepatitis B prophylaxis post-liver transplant without maintenance hepatitis B immunoglobulin therapy. Clin Transplant. 2006 Mar-Apr;20(2):206-10.
* 273. Paraskevas S, Kandaswamy R, Humar A, Gillingham KJ, Gruessner RW, Payne WD, Najarian JS, Sutherland DE, Matas AJ: Risk factors for rising creatinine in renal allografts with 1 and 3 yr survival. Clin Transplant. 2006 Nov-Dec;20(6):667-72.
* 274. Humar A, Gillingham K, Kandaswamy R, Payne W, Matas A: Steroid avoidance regimens: a comparison of outcomes with maintenance steroids versus continued steroid avoidance in recipients having an acute rejection episode. Am J Transplant. 2007 Aug;7(8):1948-53.
* 275. Humar, A, Crotteau S, Gruessner A, Kandaswamy R, Gruessner R, Payne W, Lake J. Steroid minimization in liver transplant recipients: impact on hepatitis C recurrence and posttransplant diabetes. Clin Transplant. 2007 Jul-Aug;21(4):526-31.
* 276. Humar A, Gillingham K, Kandaswamy R, Payne W, Matas A. Steroid avoidance regimens: a comparison of outcomes with maintenance steroids versus continued steroid avoidance in recipients having an acute rejection episode. Am J Transplant. 2007 Aug;7(8):1948-53.
Top of page
BOOK CHAPTERS:
1. Payne WD: Peritoneal dialysis. In Simmons RL, Finch MD, Ascher NL, and Najarian JS (eds): Manual of Vascular Access, Organ Donation, and Transplantation. New York: Springer-Verlag, 1984, pp 88-101.
2. Fryd DS, Migliori R, Simmons RL, Chavers B, Dunn D, Payne W, Canafax DM, Sutherland DER, Mauer SM, and Najarian JS: Renal transplantation at the University of Minnesota during the 1980's. In Terasaki P (ed): Clinical Transplants 1987. Los Angeles, CA: UCLA Tissue Typing Laboratory, 1987, pp 167-181.
3. Fryd DS, Canafax DM, Matas AJ, Dunn D, Payne WD, Sutherland DER, and Najarian JS: A comparison of two cyclosporine protocols at the University of Minnesota. . In Terasaki P (ed): Clinical Transplants 1988. Los Angeles, CA: UCLA Tissue Typing Laboratory, 1988, pp 79-90.
4. Chavers BM, Matas AJ, Nevins TE, Mauer SM, Sutherland DER, Payne W, Dunn D, Gillingham K, and Najarian JS: Results of pediatric kidney transplantation at the University of Minnesota. . In Terasaki P (ed): Clinical Transplants 1989. Los Angeles, CA: UCLA Tissue Typing Laboratory, 1989, pp 253-266.
5. Detre KM, Belle SH, Carr MA, Gavaler JS, Kelsey SF, Wei YL, Gross GR, H iatt JR, Klintmalm G, Payne WD, van Thiel D, Wiesner RH, and Hoofnagle JH: A report from the NIDK liver transplantation database. In Terasaki P (ed): Clinical Transplants 1989. Los Angeles, CA: UCLA Tissue Typing Laboratory, 1989, pp 129-141.
6. Wrenshall LE, Sutherland DER, Matas AJ, Bolman RM III, Payne WD, and JJCerra FB: Critical care of the transplant patient. In Berk JL and Sampliner JE (eds): Handbook of Critical Care, Boston: Little, Brown and Company, 1990, pp 729-752.
7. Chavers BM, Matas AJ, Nevins TE, Mauer SM, Sutherland DER, Payne WD, Dunn DL, Gillingham K, and Najarian JS: Present status of kidney transplantation in children at the University of Minnesota. In Golematis B (ed): Chrysophillis, Athens, Greece: 1990, pp 601-612.
8. Tzardis PJ, Gruessner RWG, Matas AJ, Fryd DS, Payne WD, Dunn DL, Sutherland DER, and Najarian JSJ: Renal transplantation in patients with polycystic kidney disease: A single center experience. In Golematis B (ed): Chrysophillis, Athens, Greece: 1990, pp 395-406.
9. Roberts JP, Ascher NL, and Payne WD: Clinical and surgical considerations in hepatic transplantation. In Letourneau JG, Day DL, and Ascher NL (eds): Radiology of Organ Transplanation. Chicago, IL: Year Book Medical Publishers, 1991, pp 161-169.
10. Sutherland ER,Gruessner RWG, Matas AJ,Lloveras G, Fryd DS, Dunn DL, Payne WD, and Najarian JS: Transplantation of single and double kidneys from pediatric donors. In Abouna GM, Kumar MSA, White AG (eds): Organ Transplantation 1990. Dordrecht: Kluwer Academic Publishers, 1991, pp 201-202.
11. Perez RV, Matas AJ, Gillingham KJ, Payne WD, Canafax DM, Dunn DL, Gores PF, Sutherland DER, and Najarian JS: Lessons learned and future hopes: Three thousand renal transplants at the University of Minnesota. In Terasaki P (ed): Clinical Transplants 1990. Los Angeles, CA: UCLA Tissue Typing Laboratory, 1991, pp 217-231
12. Hu W-S, Nyberg SL, Shatford RA, Payne WD, and Cerra FB: Cultivation of hepatocytes in a new entrapment reactor: A potential bioartificial liver. In Sasaki R an Ikura K (eds): Animal Cell Culture and Production of Biologicals. Proceedings of the Third Annual Meeting of the Japanese Association for Animal Cell Technology, held in Kyoto, December 11-13, 1991. Kluwer Academic Publishers, The Netherlands, 1991, pp 75-80.
13. Payne W: Results of retransplantation. Chapter in: Maddrey WD (ed): Transplantation of the Liver, Second Edition. East Norwalk, CT: Appleton & Lange, 1995.
14. Payne W: Results of retransplantation. Chapter in: Maddrey WD (ed): Transplantation of the Liver, Second Edition. East Norwalk, CT: Appleton & Lange, 1995.
15. Weisdorf SAS and Payne WD: Gastrointestinal complications of solid organ and bone marrow transplantation. In M Feldman, BF Scharschmidt and MH Sleisenger (eds): Gastrointestinal and Liver Disease, 6th Edition, Volume 1. Philadelphia, PA: WB Saunders Company, 1998, pp 376-386.
16. Moss A, Najarian JS, Sutherland DE, Payne WD, Gruessner RW, Humar A, Kandaswamy R, Gillingham KJ, Dunn DL, Matas AJ. 5,000 kidney transplants—a single-center experience. In: Cecka and Terasaki, Eds. Clinical Transplants 2000. UCLA Immunogenetics Center, Los Angeles, CA, 2001. (Pp. 159-71)
1. Humar, A, Matas AJ, Payne WD. Atlas of Organ Transplantation. Springer-Verlag London Limited, 2006.
Top of page
ABSTRACTS:
1988
Estrin JA, Belani KG, Ascher NL, Payne W, and Najarian JS: Hemodynamic changes in liver transplant recipients during reperfusion of the homograft. Presented at American Society of Anesthesiology meeting, October, 1988. Published in Anesthesiology 69: 3A: A172, 1988.
Letourneau JG, Hunter DW, Ascher NL, Roberts JP, Payne W, Thompson WM, Castañeda-Zuñiga WR, and Day DL: Radiologic diagnosis and treatment of biliary complications after hepatic transplantation in children. Presented at Radiological Society of North America meeting, November 27-December 2, 1988 in Chicago, p. 151.
Letourneau JG, Hunter DW, Ascher NL, Roberts JP, Payne W, Thompson WM, Castañeda-Zuñiga WR, and Day DL: Radiologic diagnosis and treatment of biliary complications after hepatic transplantation. Presented at Radiological Society of North America meeting, November 27-December 2, 1988 in Chicago, p. 411.
Letourneau JG, Hunter DW, Ascher NL, Roberts JP, Payne W, Thompson WM, Castañeda-Zuñiga WR, and Day DL: Vascular imaging of the upper abdomen before and after hepatic transplantation. Presented at Radiological Society of North America meeting, November 27-December 2, 1988 in Chicago, p. 411.
Fasola CG, Payne WD and Fryd DS: Kidney retransplantation: Evolution of treatment and results over 20 years. Presented at the XII International Congress of the Transplantation Society, August 14-19, 1998 in Sydney, Australia. Published in Transplant Proc 21: 1: 2165-2167, 1989.
Mauer SM, Bumgardner GL, Dunn DL, and Payne WD: 1-15 year results of renal transplantation in patients with systemic lupus erythematosus (SLE) at a single center. Presented at the XII International Congress of the Transplantation Society, August 14-19, 1998 in Sydney, Australia. Published in Transplant Proc 21: 1: 2031-2032, 1989.
Stock PG, Ascher NL, Roberts JP, Payne WD, Belani K, Estrin J, and Najarian JS: Rapid infusion technique as a safe alternative to venovenous bypass in orthotopic liver transplant (TX). Presented at the XII International Congress of the Transplantation Society, August 14-19, 1998 in Sydney, Australia. Published in Transplant Proc 21: 1: 2322-2325, 1989.
Freese DK, Snover D, Payne W, Ascher N, and Sharp HL: Chronic rejection after liver transplant. Presented at American Association for the Study of Liver Diseases, November 7-8, 1988 in Chicago.
Bloomer JR, Weimer MK, Bossenmaier IC, Snover DC, Payne WD, and Ascher NL: Liver transplantation in protoporphyria. Presented at the International Association for the Study of the Liver, November 3-4, 1988 in Toronto. Published in Hepatology 8: (Sept/Oct): Abstract 912: 1447, 1988.
1989
Bumgardner G, Payne WD, Matas AJ, Cahill D, Chen S, and Ascher NL: In vivo immunogenicity of purified MHC class I + hepatocytes. FASEB 3: 4: A1125 (#5220), 1989.
Rank JM, Sharp HL, Freese DK, Glock MS, Payne WD, and Bloomer JR: Effect of hematin and liver transplant in tyrosinemia I related neurologic dysfunction. Gastroenterology 96: A6-47, 1989.
Bumgardner GL, Payne WD, Cahill D, Chen S, Cunningham T, Matas AJ, and Ascher NL: Purified hepatocytes stimulate allospecific cytotoxic response in vivo. Presented to The Society of University Surgeons, February 9-11, 1989, Baltimore, MD.
Letourneau JG, Hunter DW, Ascher NL, Roberts JP, Payne WD, Najarian JS, Thompson WM, Castañeda-Zuñiga WR, and Day DL: Radiologic diagnosis and treatment of biliary complications after hepatic transplantation. Presented at the American Roentgen Ray Society 1989 Annual Meeting, May 7-12, 1989, New Orleans, LA.
Min DI, Canafax DM, Wrenshall L, Matas AJ, Fryd DS, Dunn DL, Payne WD, Sutherland DER, and Najarian JS: An increased frequency of late rejection occurs in cadaveric renal allograft recipients receiving sequential immunosuppressive therapy. Presented at the American College of Clinical Pharmacy Annual Meeting, August 7, 1989, Kansas City, MO. Pharmacotherapy 9: 192 (#131), 1989.
Freese D, Snover D, Gross C, Savik K, Sharp HL, and Payne W: Is chronic liver rejection reversible? An analysis of vanishing bile duct syndrome and obliterative endarteritis. Presented to the American Society of Transplant Physicians 8th Annual Meeting, Chicago, IL, May 30-31, 1989.
Bumgardner GL, Ascher NL< Cahill D, Chen S, Payne WD, and Matas AJ: Analysis of the in vivo and in vitro immune response to purified hepatocytes (HC). Presented at the American Society of Transplant Surgeons, Chicago, IL, May 31-June 2, 1989.
Fabrega A, Matas A, Payne W, Fryd D, and Najarian J: Long-term results of 123 consecutive HLA-identical (HLA-ID) living related transplants. Presented at the American Society of Transplant Surgeons, Chicago, IL, May 31-June 2, 1989.
Bumgardner GL, Matas A, Payne W, Elick B, Dunn D, Fryd D, Sutherland D, and Najarian J: Posttransplant pregnancy at a single center. Poster presentation at the American Society of Transplant Physicians 8th annual Meeting, Chicago, IL, May 30-31, 1989.
Wrenshall L, Matas A, Canafax D, Min D, Fryd D, Dunn D, Payne W, Sutherland D, and Najarian J: Increased incidence of late rejection in cadaveric recipients receiving sequential therapy. American Society of Transplant Surgeons/Physicians Annual Meeting. Chicago, IL, June 1, 1989.
Bumgardner GL, Ascher NL, Chen S, Cunningham TR, Payne WD, and Matas AJ: Immunosuppressive effects of hepatocyte cytosol (HCC) is mediated by arginase. Presented to the American College of Surgeons Annual Meeting, Chicago, IL, October 15-20, 1989.
Fasola C, Matas A, Payne W, and Najarian J: Reversal of acute liver failure in a large animal by autologous hepatocyte (HC) transplantation. Presented to the American College of Surgeons Annual Meeting, Chicago, IL, October 15-20, 1989.
Gruessner RWG, Dunn DL, Tzardis PJ, Tomadze G, Payne WD, Matas AJ, Sutherland DER, and Najarian JS: Simultaneous pancreas/kidney transplant versus kidney transplants alone in diabetic patients with nephropathy: Comparison of outcome and morbidity. Presented to 2nd International Congress on Pancreatic and Islet Transplantation, September 24-29, 1989.
Bumgardner GL, Chen S, Ascher NL, Payne WD, and Matas AJ: macrophages in immune response to hepatocytes. Presented to the Association for Academic Surgery, 23rd Annual Meeting, Louisville, KY, November 15-18, 1989.
Gross CR, Savik SK, Strasburg K, Bloomer JR, Sharp HL, and Payne WD: Predicting outcome post liver transplant based on selected recipient characteristics. Published in Proceedings of the American Association for The Study of Liver Diseases Annual Meeting, October 28-31, 1989.
1990
Almond PS, Bumgardner GL, Cunningham BS, Chen S, Payne WD, and Matas AJ: Correlation of Class I antigen expression with immunogenicity. Presented to Society for University Surgeons Meeting, Los Angeles, CA, February 8-10, 1990. Published in Curr Surg 47: 262-264, 1990.
Santilli SM, Payne W, Hunter DW, and Knighton DR: Comparison of standard angiography with balloon occlusion angiography of the lower extremity: Effect upon operative procedure and limb salvage. Presented to Minnesota Vascular Society, December 28, 1989.
Stoeblen F, Troppman JC, Payne WD, Dunn DL, Sutherland DER, Matas AJ, and Najarian JS: The use of living related donors in kidney retransplantation. Presented to 4th U of M Research Poster Session: Basic and Applied Research in Academia and Industry, Minneapolis, MN May 15, 1990.
Almond PS, Troppmann C, Escobar FS, Frey DJ, Payne WD, and Matas AJ: The economic impact of ATN on hospitals with fixed rate reimbursement. Presented to the American Society of Transplant Physicians meeting, Chicago, IL, May 29-30, 1990.
Loeffler CM, Matas AJ, Kruse L, Mayoral JL, Payne WD, Dunn DL, Sutherland DER, and Najarian JS: Patients with non HsAg+ liver disease are not at increased risk for renal transplantation. Presented to the American Society of Transplant Physicians meeting, Chicago, IL, May 29-30, 1990.
Fasola CG, Kim YS, Dunn DL, Payne WD, Sutherland DER, Matas AJ, Najarian JS: Kidney retransplantation at a single institution: Prediction of the outcome of third kidney transplant (tx) based on the patient's previous tx history. Presented to the American Society of Transplant Physicians meeting, Chicago, IL, May 29-30, 1990
Fischel RJ, and Payne WD: Doctor: What are my chances? Presented at the American Society of Transplant Surgeons meeting, Chicago, IL, May 30-June 1, 1990.
Almond PS, Matas AJ, Escobar FS, Troppmann C, Payne WD, Dunn DL, Sutherland DER, Gillingham KJ, and Najarian JS: The effects of cyclosporine and non-immunologic loss of the primary renal allograft on second renal transplants. Presented to the American Society of Transplant Physicians meeting, Chicago, IL, May 29-30, 1990.
Fischel RJ, Gillingham KJ, and Payne WD: Long-term outcome in one year graft survivors - Comparison of diabetic and nondiabetic populations. Presented to XIII International Transplantation Congress, San Francisco, CA, August 19-24, 1990.
Payne WD, Almond P, Morel P, Chavers B, Kashtan C, Mauer S, and Nevins JT: Transplanted children with long-term graft function have excellent quality of life. Presented at the XIII International Transplantation Congress, San Francisco, CA, August 19-24, 1990.
Bumgardner GL, Chen SC, and Payne WD: Evidence for indirect presentation of hepatocyte (HC) MHC class I antigen in HC-sponge matrix allografts. Presented to XIII International Transplantation Congress, San Francisco, CA, August 19-24, 1990.
Fasola C, Kim YS, Manivel JC, Cerra F, Matas AJ, and Payne WD: Reversal of acute hepatic failure in pigs by xenogeneic hepatocyte (HC) transplantation and by injection of supernatant from xenogeneic HC cultures. Presented at Surgical Forum meeting, October 7-12, 1990.
Belani KG, Naasz M, Lura D, Gillingham K, and Payne W: Comparison of blood product usage between infants and older children du ring orthotopic liver transplantation. Presented at the First Symposium of the International Society for Perioperative Care in Liver Transplantation, Pittsburgh, Pennsylvania, September 7-8, 1990.
Belani KG, Lura D, Payne W, and Estrin JA: Behavior of oxygenation variables in functioning grafts during orthotopic liver transplantation. Presented at the First Symposium of the International Society for Perioperative Care in Liver Transplantation, Pittsburgh, Pennsylvania, September 7-8, 1990.
Fasola CG, Kim YS, Aeder MI, Dunning M, Mueller R, Nakheh RE, Almond PS, Payne WD, and Dunn DL: Pretransplant immunotherapy can prolong function of small bowel allografts in dogs. Presented to The Society of University Surgeons, 52nd Annual Meeting, Galveston, TX, Feb. 7-9, 1991.
1991
Perez R, Matas AJ, Payne WD, Dunn DL, Mauer SM, Chavers B, Nevins T, Kashtan C, and Najarian JS: Infectious complications in pediatric renal transplant recipients. Presented to Organ Transplants in Children - A Perspective for the 90's, Philadelphia, PA, April 7-9, 1991.
Freese DK, Payne WD, Sharp HL, and Najarian JS: Simultaneous liver/kidney transplantation in children. Presented at Organ Transplants in Children - A Perspective for the 90's, Philadelphia, PA, April 7-9, 1991.
Schwarzenberg SJ, Freese DK, Gores PF, and Payne WD: Resolution of severe intrapulmonary shunting after liver transplantation. Presented at Organ Transplants in Children - A Perspective for the 90's, Philadelphia, PA, April 7-9, 1991.
Moss A, Almond PS, Matas AJ, Gillingham K, Troppmann C, Payne WD, Dunn D, Sutherland DER, and Najarian JS: Risk factors for second (2o) renal transplants immunosuppressed with cyclosporine. Poster presented at the American Society of Transplant Physicians meeting, Chicago, IL, May 28-29, 1991.
Brayman KL, Vianello A, Xenos L, Gruber S, Gillingham K, Morel P, Matas AJ, Dunn DL, Gores PF, Payne WD, Sutherland DER, and Najarian JS: Analysis of lethal and non-lethal pulmonary embolism in renal transplant recipients in the pre- and post-cyclosporine eras. Poster presented at the American Society of Transplant Physicians meeting, Chicago, IL, May 28-29, 1991.
Schweitzer EJ, Matas AJ, Gillingham KJ, Payne WD, Gores PF, Dunn DL, Sutherland DER, and Najarian JD: Causes of renal allograft loss: Progress in the '80s, challenges for the '90s. Presented at the American Society of Transplant Physicians meeting, Chicago, IL, May 28-29, 1991.
Brayman KL, Gillingham KJ, Morel P, Matas AJ, Sutherland DER, Dunn DL, Gores PF, Payne WD, and Najarian JS: Renal transplants in the elderly - The impact of patient death with a functioning graft. Poster presented at the American Society of Transplant Physicians meeting, Chicago, IL, May 28-29, 1991.
Perez R, Matas AJ, Payne WD, Dun DL, Mauer SM, Chavers B, Nevins T, Kashtan C, and Najarian JS: Infectious complications in pediatric renal transplant recipients. Presented at the American Society of Transplant Physicians meeting, Chicago, IL, May 28-29, 1991
Dunn DL, Gillingham KJ, Brayman KL, Mayoral JL, Payne WD, Matas AJ, Sutherland DER, and Najarian JS: Influence of pretransplant cytomegalovirus (CMV) serology and treatment of rejection upon invasive CMV disease after kidney and kidney-pancreas transplantation. Poster presented at the Third International Congress on Pancreatic and Islet Transplantation Symposium on Artificial Insulin Delivery system. Lyon, France, June 6-8, 1991.
Brayman K, Stephanian E, Matas A, Schmidt W, Payne W, Sutherland D, Gores P, Najarian J, and Dunn D: Analysis of infectious complications occurring in solid organ transplant recipients in the quadruple immunosuppression era. Presented to Surgical Infections Society meeting.
Shatford RA, Nyberg SL, Payne WD, Hu W-S, and Cerra FB: A hepatocyte bioreactor as a potential bioartificial liver: Demonstration of prolonged tissue specific functions. Presented at the American College of Surgeons Meeting, Chicago, IL, October 21, 1991.
Troppmann C, Payne WD, Dunn DL, Sutherland DER, Matas AJ, and Najarian JS: The long-term impact of donor and acute tubular necrosis on cadaveric renal transplantation. Presented at Organ Transplants in Children - a Perspective for the 90's, Philadelphia, PA, April 7-9, 1991.
Troppmann C, Payne WD, Dunn DL, Sutherland DER, Matas AJ, and Najarian JS: The long-term impact of donor and acute tubular necrosis on cadaveric renal transplantation. Poster presented at the 5th European Society for Organ Transplantation Congress, The Netherlands, October 7-10, 1991.
Shatford RA, Nyberg SL, Payne WD, Hu W-S, and Cerra FB: Hepatocyte function in a hollow fiber bioreactor: A potential bioartificial liver. Presented at the Association for Academic Surgery, Colorado Springs, CO, November 23, 1991.
Nyberg S, Shatford R, Payne W, Hu W-S, and Cerra F: Rapid determination of hepatocyte viability with FDA staining and flow cytometry. Presented at the American College of Gastroenterology, Boston, MA, October 15, 1991.
Rank JM, Freese DK, Payne W, and Bloomer JR: Neurologic dysfunction associated with end-stage protoporphyric liver disease. Presented at the American Association for the Study of Liver Diseases, Chicago, IL, November 2-5, 1991. Hepatology 14: 4: Pt 2: 143A, 1991.
Rank JM, Key NS, Freese DK, Payne WD, Hammerschmidt DE, and Bloomer JR: Hemolysis associated with end-stage protoporphyric liver disease and transplantation. Hepatology 14: 4: Pt 2: 287A, 1991.
Key NS, Rank JM, Freese DK, Payne WD, Bloomer JR, and Hammerschmidt DE: Hemolytic anemia in (erythropoietic) protoporphyria with end-stage liver disease: Possible role of oxidant mediated membrane damage. Poster presented at The American Society of Hematology 33rd Annual Meeting, Denver, December 6-10, 1991l Blood 78: 10: Suppl 1: 98a, 1991.
Nyberg SL, Shirabe K, Amiot B, Payne WD, Hu W-S, and Cerra FB: Glucose homeostasis is preserved by a bioartificial liver in the anhepatic rabbit. Presented at the Society of University Surgeons Meeting, Cincinnati, OH, February 15, 1992.
Nyberg SL, Shirabe K, Amiot B, Payne WD, Cerra FB, and Hu W-S: Support of liver failure in an anhepatic rabbit model by a bioartificial liver. Presented at the JAACT Annual Meeting, November 13-15, 1991, Kyoto, Japan.
1992
Granger DK, Gillingham KJ, Sutherland DER, Payne WD, Najarian JS, and Matas A: Impact of extrarenal disease on graft and patient outcome in renal allograft recipients. Poster presented at the American Society of Transplant Surgeons meeting, May 27-29, 1992.
Jones JW, Matas AJ, Gillingham KJ, Gores PF, Payne WD, Gruessner R, Sutherland DER, and Najarian JS: The effect of renal transplantation on employment and disability. Poster presented at the American Society of Transplant Surgeons meeting, May 27-29, 1992.
Granger D, Gillingham K, Sutherland D, Payne W, Gores P, Gruessner R, Najarian J, and Matas A: Extrarenal disease affects posttransplant patient and graft outcome in renal allograft recipients. Presented to the XIV International Congress of the Transplantation Society, Paris, France, August 16-21, 1992.
Payne W, Jones J, Dunn D, Gores P, and Gruessner R: Employment and disability after renal transplantation. Presented to the XIV International Congress of the Transplantation Society, Paris, France, August 16-21, 1992.
Basadonna G, Matas A, Gillingham K, Payne W, Dunn D, Sutherland D, and Najarian J: Does early vs. late rejection affect renal transplant graft los to chronic rejection?: Presented to the XIV International Congress of the Transplantation Society, Paris, France, August 16-21, 1992.
Freese D, Ho S, Snover D. Bloomer J, Rank J, Sharp H, Knaak M, Allen J, Hamman K, and Payne W: Chronic hepatitis after liver transplantation: Etiology and outcome. Presented at the North American Society for Pediatric Gastroenterology and Nutrition meeting, Chicago, IL, October 30-31, 1992.
Freese D, Ho S, Snover D, Bloomer J, Rank J, Sharp, Knaak M, Allen J, Haman K, and Payne W: Chronic hepatitis after liver transplantation: Etiology and outcome. Presented to the American Association for the Study of Liver Diseases, Chicago, IL, October 31-November 3, 1992. Hepatology 16: 2: Pt. 2: 48A, 1992.
Rank JM, Payne WD, and Bloomer JR: Liver transplantation in protoporphyric liver disease. Presented to the American Association for the Study of Liver Diseases, Chicago, IL, October 31-November 3, 1992. Hepatology 16: 2: Pt. 2: 47A, 1992.
Arrazola L, Basadonna G, Gores PF, Bloomer J, Freese D, Sharp H, and Payne WD: Treatment of acute and subacute hepatic failure due to hepatitis A virus by liver transplantation. Hepatology 16: 2: Pt. 2: 272A, 1992.
Nyberg SL, Peshwa MV, Payne WD, Hu W-S, and Cerra FB: Support of hepatic biochemical function during hollow fiber bioartificial liver hemoperfusion. Hepatology 16: 2: Pt. 2: 287A, 1992.
Nyberg SL, Payne WD, Hu W-S, and Cerra FB: Matrigel improves function of gel-entrapped hepatocytes: Implications for the hollow fiber bioartificial liver. Hepatology 16: 2: Pt. 2: 286A, 1992.
Kim YS, Fasola CG, Schlumpf R, Nakhleh RE, Manivel JC, Payne WD, Sutherland DER, Najarian JS, and Dunn DL: Successful canine small bowel preservation in simple cold storage for 48hours using a Dextran-40-based solution. Presented to the XIV International Congress of the Transplantation Society, Paris, France, August 16-21, 1992.
1993
Troppmann C, Almond PS, Fasola C, Gruessner RWG, Gores PF, Dunn DL, Payne WD, Sutherland DER, Matas AJ, and Najarian JS: The effect of Minnesota antilymphocyte globulin (MALG) on T-lymphocytes and their subsets during induction therapy in pediatric renal transplantation. Presented at the First International Congress on Pediatric Transplantation, Minneapolis, MN, August 29-September 1, 1993.
Fasola C, Gillingham K, Troppmann C, Gruessner RWG, Payne W, Matas A, and Najarian J: Kidney transplant or retransplantation can effectively treat congenital nephrotic syndrome. A single center experience. Presented at the First International Congress of Pediatric Transplantation, Minneapolis, MN, August 29-September 1, 1993.
Arrazola L, Nino-Murcia A, Basadonna G, Gores PF, Bloomer J, Freese D, Sharp H, Ascher NL, and Payne JWJD: Liver transplantation, an effective treatment for liver failure due to hepatitis A virus. Presented to the Second Congress of the International Society of Liver Transplantation, Toronto, October 6-8, 1993.
Nyberg JSL, Peshwa MV, Shatford RA, Sielaff TD, Amiot B, Wu FJ, Hu MY, Remmel RP, Menn HJ, Payne WD, Bloomer JR, Cerra FB, and Hu W-S: A xenogeneic bioartificial (BAL) liver for application in acute human fulminant hepatis. Poster presentation at Whitaker Foundation Grantee Conference, Snowbird, UT, July 30-August 1, 1993.
Peshwa MV, Nyberg SL, Amiot B, Sielaff TD, Wu FJ, Hu MY, Remmel RP, Menn HJ, Payne WD, Bloomer JR, Cerra FB, and Hu W-W: Optimization, cale-up and evaluation of xenogeneic bioartificial liver (BAL) for application in acute human fulminant hepatitis. Presented at the First International Conference on Cellular Engineering, Keele University, UK, September 12-15, 1993.
Nyberg SL, Peshwa MV, Amiot B, Sielaff TD, Wu FJ, Hu MY, Remmel RP, Mann JH, Payne WD, Bloomer JR, Cerra FB, and Hu W-S: Application of isolated hepatocytes or spheroid aggregates in a gel-entrapment, hollow fiber bioreactor for use as a xenogeneic bioartificial liver. Presented at the 4th Kyoto Biomedical Engineering Symposium, Kyoto, Japan, October 21-23, 1993.
1994
Troppmann C, Benedetti E, Chiou A, Gruessner RWG, Dunn DL, Gores P, Payne WD, Matas AJ, and Najarian JS: Upper gastrointestinal ulcer complications after 956 renal transplants - incidence, localization, outcome and impact on graft and patient survival. Poster presentation at the American Society of Transplant Physicians, Chicago, IL, May 16-18, 1994.
Gutowski K, Fasola C, Goodale R, Najarian J, Sutherland D, Dunn D, Goes P, Payne W, Gruessner JR: Laparoscopic drainage of lymphocele after kidney transplants: Indications and limitations. Poster presentation at XV World Congress of the Transplantation Society meeting, Kyoto, Japan, August 28-September 2, 1994.
1996
Nyberg C, Remmel R, Sielaff T, Hu M, Mann H, Payne W, Hu W-S, and Cerra F: Development of a gel-entrapped bioartificial liver for support of liver failure. Presented at the International Congress on Hepatocytes - Applications in Cell Biology, Toxicology and Medicine, Tübingen, Germany, September 25-28, 1996.
1997
Humar A, Gillingham K, Johnson E, Payne WD, Dunn DL, Sutherland DER, Gruessner RWG, Wrenshall LE, Najarian JS, and Matas AJ: Effect of initial show graft function on renal allograft rejection and survival. Presented at the American Society of Transplant Surgeons Annual Meeting, May 14-16, 1997.
Humar A, Johnson E, Payne WD, Gruessner RWG, Matas AJ: The acutely ischemic extremity after transplant: An approach to management. Presented at the American Social of Transplant Surgeons Annual Meeting, May 14-16, 1997.
1998
Humar A, Mauer M, Durand B, Payne W, Sharp H, Gruessner R: Kidney and liver transplantation from living related and cadaver donors for primary hyperoxaluria type 1. Presented at the Third International Congress on Pediatric Transplantation, July 8-10, 1998.
Humar A, Sharp H, Payne W, Walsh J, Gruessner R: Preoperative radiologic assessment of living related liver donors. Presented at the Third International Congress on Pediatric Transplantation, July 8-10, 1998.
Kandaswamy R, Hassoun A, Humar A, Dunn D, Najarian J, Sutherland D, Payne W, Matas A: Retransplants - Markedly improved outcome using CSA-based immunosuppression. Presented at the 31st American Society of Nephrology, October 25-28, 1998.
Matas A, Granger D, Humar A, Kandaswamy R, Hassoun A, Dunn D, Najarian J, Payne W, Sutherland D: When should I use the new immunosuppressive agents? Presented at the 31st American Society of Nephrology, October 25-28, 1998.
1999
Matas A, Gillingham K, Humar A, Dunn DL, Payne W, Sutherland DER, Najarian, JS: Decreased acute kidney transplant rejection is associated with decreased chronic rejection. Poster presentation at the AST 18th Annual Meeting, Chicago, May 1999.
Humar A, Mauer M, Durand B, Payne W, Sharp H, Gruessner R. Kidney and liver transplantation from living related and cadaver donors for primary hyperoxyluria Type I. Poster presentation at the AST 18th Annual Meeting, Chicago, May 1999.
Humar A, Sharp H, Payne W, Walsh J, Gruessner R. Preoperative radiologic assessment of living related liver donors. Poster presentation at the AST 18th Annual Meeting, Chicago, May 1999.
2000
Matas A, Gillingham K, Humar A, Payne W, Kandaswamy R, et al. The impact (?) of HLA-ABDR match on chronic rejection (CR). Presented at the Annual Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation. Chicago, May 13-17, 2000.
Humar A, Durand B, Knaak M, Shriver L, Kallis A, Lake J, Payne W. Sharing of livers fo rstatus 1 recipients in Region 7 - A good thing. Submitted to Transplant 2001 Joint Meeting, Chicago, May 11-16, 2001.
Humar A, Kandasway R, Sielaff T, Gruessner R, Knaak M, Lake J, Payne W. Split-liver transplants for 2 adult recipients: An initial experience. Submitted to Transplant 2001 Joint Meeting, Chicago, May 11-16, 2001.
Ramcharan T, Rogers M, Kandaswamy R, Sielaff T, Gruessner RW, Lake J, Payne W, Humar A. Outcome of other organs recovered during in situ split liver procurements. Submitted to Transplant 2001 Joint Meeting, Chicago, May 11-16, 2001.
Humar A, Payne W, Ramcharan T, Denis R, Gillingham K, Matas A. The impact of increasing donor age on long-term kidney graft survival --each year counts. Submitted to Transplant 2001 Joint Meeting, Chicago, May 11-16, 2001.
2001
Humar A, Kandaswamy R, Sielaff T, Gruessner RW, Knaak M, Lake J, Payne WD. Split-liver transplant for 2 adult recipients: An initial experience. Poster presentation at Second Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation. Chicago, May 11-16, 2001.
Ramcharan T, McHugh L, Kandaswamy R, Gruessner RW, Payne WD, Suthrland DER, Humar A, Dunn DL, Najarian JS, Matas. Living kidney donation: Long-term (20-37 yrs.) consequences. Oral presentation at Second Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation. Chicago, May 11-16, 2001.
Humar A, Durand B, Knaak M, Shriver L, Kallis A, Lake J, Payne W. Sharing of livers for status 1 recipients in Region 7 – A good thing. Oral presentation at the Second Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation. Chicago, May 11-16, 2001.
Ramcharan T, Rogers M, Kandaswamy R, Sielaff T, Gruessner RW, Lake J, Payne W, Humar A. Outcome of other organs recovered during in situ split liver procurements. Poster presentation at Second Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Chicago, May 11-16, 2001.
Humar A, Payne W, Ramcharan T, Denny R, Gillingham K, Matas AJ. The impact of increasing donor age on long-term kidney graft survival – each year counts. Oral presentation at the Second Annual Joint meeting of the American Society of Transplant Surgeons and the American Society of Transplantation.Chicago, May 11-16, 2001.
Ramcharan T, Gruessner AC, Paraskevas S, Humar A, Payne WD, Gruessner RWG. Long-term results with 37 pediatric liver transplants (Txs) for α-1 antitrypsin deficiency (a1AD): A single center experience. Oral presentation at the Joint Meeting of ILTS, ELTA, LICAGE, Berlin, Germany, July 11-13, 2001.
2002
Humar A, Ibrahim H, Khwaja K, Asolati M, Gillingham K, Payne WD, Matas AJ. Kidney transplant (KTx) in recipients with a high PRA – is there any value in trying to decrease this before transplant? Poster presentation at Third Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Washington, D.C., April 2002.
Humar A, Sielaff T, Kandaswamy R, Gruessner RW, Knaak M, Kalis A, Shriver L, Lake J, Payne WD. Split-liver transplants (SLTs) for 2 adult recipients: The key is proper donor and recipient selection. Oral presentation at the Third Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Washington, D.C., April 2002.
Also a poster presentation at 8th Congress International Liver Transplantation Society, Chicago, June 2002.
Humar A, Sielaff T, Glessing B, Kalis A, Nelson S, Denny R, Khwaja K, Lake J, Payne WD. Donor vascular and biliary anatomical variations encountered during cadaver in situ liver splitting for 2 adult recipients. Poster presentation at the Third Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Washington, D.C., April 2002.
Humar A, Glessing B, Sielaff T, Lake J, Payne WD. Outcomes after cadaver (CAD) vs. living donor (LD) right lobe liver transplants – how much does dying affect initial graft function? Poster presentation at the Third Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Washington, D.C., April 2002.
Denny R, Noreen H, Gruessner AC, Humar A, Payne WD, Sharp H, Gruessner RW. Positive T-cell cross-match and high PRA have no impact on long-term patient and graft survival in pediatric liver transplant recipients. Poster presentation at the Third Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Washington, D.C., April 2002.
Khwaja K, Gillingham K, Humar A, Payne WD, Matas AJ, Kandaswamy R. Risk factors for 6 and 12 month serum creatinine levels – how can kidney graft survival be improved? Poster presentation at the Third Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Washington, D.C., April 2002.
Humar A, Glessing B, Sielaff T, Lake J, Payne WD. Comparison of outcomes after cadaver (CAD) vs. living donor (LD) right lobe liver transplants – how much does dy ing affect initial graft function? Poster presentation at 8th Congress International Liver Transplantation Society, Chicago, June 2002.
Humar A, Sielaff T, Glessing B, Kalis A, Nelson S, Denny R, Khwaja K. Kale J, Payne WD. Donor vascular and biliary anatomical variations encountered du ring cadaver in situ liver splitting for 2 adult recipients. Poster presentation at 8th Congress International Liver Transplantation Society, Chicago, June 2002.
Coeyman D, Sfexi M, Trenkner S, Payne WD, Lake J, Humar A. The usefulness of Doppler ultrasound (U/S) for diagnosis of vascular complications after liver transplant (LTx). Poster presentation at 8th Congress International Liver Transplantation Society. Chicago, June 2002.
Humar A, Glessing B, Ramcharan T, Knaak M, Shriver L, Gruessner AC, Lake J, Payne WD. Delayed introduction of calcineurin inhibitors (CNIs) in liver transplant (LTx) recipients with renal dysfunction – the benefits to the kidneys are long-term. Poster presentation at the 8th Congress International Liver Transplantation Society, Chicago June 2002.
Also a poster presentation at the XIX International Congress of the Transplantation Society, Miami, August 2002.
2003
Humar A, Glessing BR, Kallis A, Knaak M, Lake JR, Sielaff TD, Payne WD. Biliary and vascular anatomy of the right and left hemilivers – important anatomic lesions learned during cadaver in-situ liver splitting for 2 adult recipients. Poster presentation at American Transplant Congress, Washington, DC, May 30-June 4, 2003. Amer J Transplantation: Suppl. 5: 3: Abstract #377: 248, 2003.
Kosari, K, Williams KM, Rodrigues-Gomes ML, Rosen-Tirosh G, Lake JR, Payne WD, Sielaff TD, Humar A. Liver regeneration after living donor and cadaver split liver transplants (SLTs): donor vs. recipients. Poster presentation at American Transplant Congess, Washington, DC, May 30-June 4, 2003. Amer J Transplantation: Suppl. 5: 3: Abstract #1426: 517, 2003.
Hess D, Sielaff TD, Glessing B, Payne WD, Humar A. Right hepatic lobectomy for an underlying disease process vs. for donation in living donor liver transplant. Poster presentation at American Transplant Congress, Washington, DC, May 30-June 4, 2003. Amer J Transplantation: Suppl. 5: 3: Abstract #1417: 515, 2003.
Humar A, Khwaja K, Glessing BR, Larson E, Gruessner R, Lake JR, Gruessner AC, Sielaff TD, Payne WD. Graft weight to recipient weight (GW/RW) ratio: a poor predictor of outcome after partial liver transplants in adult recipients. Poster presentation at American Transplant Congress, Washington, DC, May 30-June 4, 2003. Amer J Transplantation: Suppl. 5: 3: Abstract #1418: 515, 2003.
Humar A,